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Due to the rapid advance of DNA sequencing technologies in recent 10 years,
large amounts of short DNA reads can be obtained quickly and cheaply. For ex-
ample, a single Illumina HiSeq machine can produce several terabytes of data sets
within a week. Metagenomics is a new scientific field that involves the analysis of
genomic DNA sequences obtained directly from the environment, enabling studies
of novel microbial systems. Metagenomics was made possible from high-throughput
sequencing technologies. The analysis of the resulting data requires sophisticated
computational analyses and data mining. In clinical settings, a fundamental goal of
metagenomics is to help people diagnose and cure disease in clinical settings. One
major bottleneck so far is how to analyze the huge noisy data sets quickly and pre-
cisely. My PhD research focuses on developing algorithms and tools to tackle these
challenging and interesting computational problems.
From the functional perspective, a metagenomic sample can be represented as
a weighted metabolic network, in which the nodes are molecules, edges are enzymes
encoded by genes, and the weights can be considered as the number of organisms
providing the functions. One goal of functional comparison between metagenomic
samples is to find differentially abundant metabolic subnetworks between two groups
under comparison. We have developed a statistical network analysis tool - MetaP-
ath, which uses a greedy search algorithm to find maximum weight subnetwork and
a nonparametric permutation test to measure the statistical significance. Unlike
previous approaches, MetaPath explicitly searches for significant subnetwork in the
global network, enabling us to detect signatures at a finer level. In addition, we
developed statistical methods that take into account the topology of the network
when testing the significance of the subnetworks.
Another computational problem involves classifying anonymous DNA sequences
obtained from metagenomic samples. There are several challenges here: (1) The
classification labels follow a hierarchical tree structure, in which the leaves are most
specific, and the internal nodes are more general. How can we classify novel se-
quences that do not belong to leaf categories (species) but belong to internal groups
(e.g., phylum)? (2) For each classification how can we compute a confidence score,
such that the users have a tradeoff between sensitivity and specificity? (3) How can
we analyze billions of data items quickly? We have developed a novel hierarchical
classifier (MetaPhyler) for the classification of anonymous DNA reads. Through
simulation, MetaPhyler models the distribution of pairwise similarities within dif-
ferent hierarchical groups with nonparametric density estimation. The confidence
score is computed by the ratio of likelihood function. For a query DNA sequence
with arbitrary length, its similarity can be calculated through linear approximation.
Through benchmark comparison, we have shown that MetaPhyler is significantly
faster and more accurate than previous tools.
DNA sequencing machines can only produce very short strings (e.g., 100bp)
relative to the size of a genome (e.g., a typical bacterial genome is 5Mbp). One of the
most challenging computational tasks is the assembly of millions of short reads into
longer contigs, which are used as the basis of subsequent computational analyses.
In this project, we have developed a comparative metagenomic assembler (Meta-
Compass), which utilizes the genomes that have already been sequenced previously,
and produces long contigs through read mapping (alignment) and assembly. Given
the availability of thousands of existing bacteria genomes, for a particular sample,
MetaCompass first chooses a best subset as reference based on the taxonomic com-
position. Then, the reads are aligned against these genomes using MUMmer-map or
Bowtie2. Afterwards, we use a greedy algorithm of the minimum set-covering prob-
lem to build long contigs, and the consensus sequences are computed by the majority
rule. We also propose an iterative approach to improve the performance. Finally,
MetaCompass has been successfully evaluated and tested on over 20 terabytes of
metagenomic data sets generated from the Human Microbiome Project.
In addition, to facilitate the identification and characterization of antibiotic
resistance genes, we have created Antibiotic Resistance Genes Database (ARDB),
which provides a centralized compendium of information on antibiotic resistance.
Furthermore, we have applied our tools to the analysis of a novel oral micro-
biome data set, and have discovered interesting functional mechanisms and ecolog-
ical changes underlying the transition from health to periodontal disease of human
mouth at a system level.
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Microorganisms comprise the majority of Earth’s biological diversity, and they
play essential functional roles in virtually all ecosystems. Although a tiny fraction
of them can induce diseases, the vast majority of microbes - life forms too tiny to
see - are actually essential to keeping us alive. For example, microbes help us digest
food, and they make Earth livable by maintaining the atmospheric conditions. In
particular, human-associated microbial communities play a fundamentally impor-
tant role in health and disease [53], and they actually do a lot of good for the health
of humans. In many natural environments, however, more than 99% of the microor-
ganisms cannot be cultured by standard laboratory techniques [104]. Metagenomics
is a new scientific field that involves the analysis of organismal DNA sequences ob-
tained directly from an environmental sample, enabling studies of microorganisms
that are not easily cultured in a laboratory. It offers a powerful lens for examining
the microbial world that has the potential to revolutionize our understanding of the
entire living world.
Metagenomic studies, pioneered in the early 2000s, have recently increased in
number and scope due to the rapid advances of high-throughput sequencing tech-
nologies, e.g., GS FLX system from 454 Life Sciences and Genome Analyzer from
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Illumina company, which permit large amounts of DNA to be sequenced quickly and
cheaply (Figure 1.1 shows the sequencing cost per Mb of DNA sequences in recent
years [110]). For example the MetaHit consortium has generated about 500 billion
base pairs raw sequences from 124 human gut samples in its initial analysis [101],
the Human Microbiome Project has produced more than 7 trillion base pair DNA
reads [20, 21], and the newly initiated Earth Microbiome Project is planning to se-
quence 200,000 samples with 6 billion base pairs per sample, totaling 1200 trillion
bp DNA (http://www.earthmicrobiome.org/). The growth of publicly available
DNA sequence data over the last two decades has been exponential, with a doubling
time of about 14 months. And the doubling time appears to be dramatically short-
ened due to next-generation sequencing and the addition of metagenomics [135].
There is a pressing need of efficient and powerful computational algorithms and
tools that can deal with the huge amount of complex and noisy metagenomic se-
quences (Figure 1.2 shows the cost compositions of a sequencing project [110]).
Motivated by these computational challenges, the goal of this dissertation is to de-
velop accurate and fast computational algorithms and tools to extract and interpret
meaningful biological information from the deluge of metagenomic sequences.
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Figure 1.1: Cost of 1 Mb of DNA sequencing. Decreasing cost of sequencing in
the past 10 years compared with the expectation if it had followed Moore’s law.
Adapted from [110].
Figure 1.2: Contribution of different factors to the overall cost of a sequencing
project across time. Adapted from [110].
1.2 Computational Problems in Metagenomics
Metagenomics introduces many interesting computational problems, e.g., gene
prediction, sequence classification and clustering, genome assembly, statistical com-
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parison, functional annotation, microbial interactions modeling, etc. Several re-
view papers have been published summarizing and describing these challenges in
detail [15, 45, 68, 102, 135]. In this section, I briefly describe some computational
problems that are relevant to my research.
1.2.1 Genome assembly
The major challenge in metagenomic assembly arises from the heterogeneous
nature of metagenomic data. Most samples contain an uneven representation of
the member species. Furthermore, the genomes in a sample frequently belong to
clusters of closely related strains whose genomes are mostly similar but differ due
to small insertion, deletion and mutations. These characteristics of metagenomic
data make it essentially impossible to construct a single genome for each species in
a sample. In contrary, a lot of genomes will be under-represented and assembled
into a highly fragmented form; while a group of closely related genomes will be
assembled together into a single genome with polymorphisms in some locations [99].
In early metagenomic projects, the assembly was usually performed with con-
ventional whole genome assemblers (e.g., Celera in [44]), which are designed for
Sanger sequencing and are based on overlap-layout-consensus algorithms. Later on,
the development of genome assembly algorithms has been boosted because of next-
generation sequencing technologies, which can produce massive amount of short
DNA reads. Several algorithms and tools have been developed specifically for this
type of data using De Bruijn graph representation (e.g., Velvet [139], SOAPden-
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ovo [79], ABySS [119], ALLPATHS [14]). We note that all of these assemblers are
designed for assembling single genome but not metagenomes. These assemblers can
be confused by two main issue: (i) uneven abundance of the genomes within a sam-
ple and (ii) polymorphisms between closely related genomes. For example, many
assemblers use depth of coverage statistics to identify DNA repeats. In metage-
nomic data, however, due to uneven coverage, these assemblers would incorrectly
label them as repeats, and avoid assembling these regions to prevent mistakes [99].
Usually, metagenomes are still assembled using these tools but with tuned parame-
ters [101].
Recently, several metagenome assemblers have been developed (e.g., Gen-
ovo [74], Meta-IDBA [96], Bambus 2 [65], MAP [71], MetaVelvet [90]). Their perfor-
mance, however, is mainly unknown in practice, since most of them have not been
tested on large-scale metagenomic data sets.
1.2.2 Sequence classification
One of the primary goals of metagenomic studies is to characterize the taxo-
nomic composition of a sample, by classifying a set of anonymous DNA reads. Sev-
eral computational tools have been developed for this purpose, e.g., PhymmBL [11]
uses a hybrid approach combining an Interpolated Markov Model framework with
similarity based BLAST search, MEGAN [55] uses the lowest common ancestor of
the top three nearest neighbors based on similarity search, AMPHORA [136] infers
a phylogenetic tree based on pair-wise similarity matrix, etc. These tools indeed
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represent significant improvements for classifying DNA reads, but the problem is
still far from solved. For example, most of these tools are not good at handling
novel taxonomic groups, require huge amount of computational power, or are not
accurate enough.
1.2.3 Statistical comparison
After computational analysis of raw metagenomic sequences (e.g., gene pre-
diction, functional annotation, sequences classification, etc), each sample can be
represented as an abundance matrix. The columns are samples, the rows are differ-
ent features and the cells represent the corresponding abundance value. Typically,
the samples come from two distinct groups in a designed study (e.g., disease and
heathy), and the goal is to find differential features that are statistically signifi-
cant. The challenge is to find the relevant features that may contribute to the
disease. Some recent studies have more complicated experimental design, for ex-
ample, within the disease and healthy samples, we may have different geographical
partitions and age stratifications. In addition, each sample may have several sets
of heterogenous features, resulting in multiple abundance matrices [137]. Several
statistical tools have been developed for comparing metagenomic samples: Metas-
tat developed a nonparametric t-test without the assumption that the underlying
distribution is normal, and for low abundance features, it utilizes Fisher’s exact
test [133]. STAMP [95] argues that knowledge of p-value from a statistical hypoth-
esis test is insufficient to make inferences about biological relevance, and it provides
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several strategies to explore the sources of potential error. LEFSe [112] proposes
a linear discriminant analysis effect size method to determine the features that are
most likely to explain differences between classes by coupling standard tests for sta-
tistical significance with additional tests encoding biological consistency and effect
relevance.
1.3 Contributions of This Dissertation
Figure 1.3 shows an overview of the projects we have finished during my PhD
research. Most of these projects are centered around the computational analysis of
high-throughput metagenomic sequence data, but the algorithms and tools we have
developed can be potentially adapted for other relevant computational problems.
1.3.1 Chapter 2 - Hierarchical Classification of Biological Sequences
MetaPhyler is a hierarchical classifier for biological sequences, and can be
used to characterize the phylogenetic diversity (or taxonomic composition) of a
microbial community. Given a training data set (including biological sequences and
their taxonomic labels), MetaPhyler automatically learns the similarity distribution
within each group induced by the given hierarchical taxonomy using non-parametric
kernel density estimation. During classification, for a query sequence, MetaPhyler
first identifies its nearest neighbor, then tries to classify it based on the best neighbor
incrementally starting from the leaf to the root of the hierarchy. A confidence score
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Figure 1.3: Overview of the projects that I have finished during my dissertation. All
of these projects are centered around the computational analysis of high-throughput
metagenomic sequence data. MetaPhyler [83] is used for taxonomic classification
of large-scale whole-metagenome shotgun sequences. MetaPath [84] uses a statisti-
cal framework to compare the abundances of weighted metabolic networks and find
functional subnetwork signatures. Antibiotic resistance genes database (ARDB) [81]
provides a centralized compendium of information on antibiotic resistance, and facil-
itates the identification and characterization of new resistance genes. MetaCompass
is a comparative assembler for metagenomic shotgun sequences. We have applied
our tools to a real human oral microbiome dataset to investigate the functional
mechanisms at a system level and the ecological changes underlying the transition
from health to disease.
this query comes from the same class as its best neighbor. MetaPhyler has been
pre-trained for a set of phylogenetic marker genes, and is directly applicable to the
classification of metagenomic sequences. Compared with other classifiers, which
usually build models for a set of flat classes, MetaPhyler models the hierarchical
groups directly, and can easily identify novel taxonomic group from the query, which
belongs to an internal class, but not the most specific leaf class.
In addition to taxonomic classification, MetaPhyler can also be adapted to
functional annotation of biological sequences. Currently, many gene annotation
tasks are performed or supervised manually by some experts, and this process usually
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is not very efficient and also introduces lots of human biases. Instead, MetaPhyler
can be trained to each functional categories or groups, the experts only need to tune
various parameters to build optimal classifiers, and the annotation process will be
performed in a completely automatic fashion.
1.3.2 Chapter 3 - Statistical comparison of weighted metabolic net-
works
Analyzing the phylogenetic diversity and comparing the taxonomic composi-
tion of metagenomic samples are only the first steps. Another challenge is to measure
and compare the biological functions performed by the environmental microbes, as
they play pivotal roles in natural environmental processes. A previous study has
suggested that the system is better characterized by its gene complement than by
its taxonomic composition, given that similar biological functions can be performed
by microbes of distinct taxonomic origins [130]. Here our goal is to find differentially
abundant metabolic subnetworks that are selected for by their local environments.
MetaPath [84] is a statistical tool that uses a greedy search algorithm to find a
maximum weight subnetwork, and a nonparametric permutation test to gauge the
statistical significance. Previous tools usually partition the whole metabolic network
into a set of connected components, which are then considered as a set of discrete
features, and traditional statistical comparisons are then performed on entire com-
ponents at a time. Unlike previous approaches, MetaPath explicitly searches for
significant subnetwork in the global network (the set of all known metabolic pro-
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cesses), enabling us to detect signatures at a finer level. In addition, we developed a
statistical method that takes into account the topology of the network when testing
the significance of the subnetworks.
1.3.3 Chapter 4 - Antibiotic resistance genes database
Antibiotic resistance genes database (ARDB) is an online database, and infor-
mation retrieval and analysis tool to facilitate the identification and characterization
of resistance genes. It unifies most of the publicly available information on antibiotic
resistance from various other database sources, e.g., NCBI Clusters of Orthologous
Groups, NCBI Conserved Domains Database, KEGG DRUG database, the Chemi-
cal Entities of Biological Interest ontology, etc. It allows the users to automatically
identify and annotate antibiotic resistance genes for new genome projects, to mine
previously identified genes and to compare the resistance profiles across samples.
In addition, the information analysis and retrieval infrastructure, and data model
can be generalized to building databases for other biological genes. Lot of biomedi-
cal information is stored in semi-structured data, and is distributed across different
database sources. ARDB also provides a framework for compiling and building such
specialized gene information databases.
1.3.4 Chapter 5 - Mining oral microbiome from a system perspective
While much is known about individual species associated with pathogenesis,
the system-level mechanisms underlying the transition from health to disease are still
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poorly understood. Through the sequencing of the 16S rRNA gene and of whole
metagenome shotgun DNA, we provide a glimpse at the global genetic, metabolic,
and ecological changes associated with periodontitis in 15 subgingival plaque sam-
ples, four from each of two periodontitis patients, and the remaining samples from
three healthy individuals. We also demonstrate the power of whole-metagenome
sequencing approaches in characterizing the genomes of key players in the oral mi-
crobiome, including an unculturable TM7 organism.
This project is accomplished through extensive collaborations with several ex-
ternal research groups, including Dr. Salomon Amar, Dr. Daniel Segre, Dr. Simon
Kasif from Boston University and Dr. Colin Stine from University of Maryland,
School of Medicine. My specific contributions to this project are mainly data analy-
ses about taxonomic diversity, statistical comparison of metabolic networks, genome
assembly and genomic variation. For example, taxonomic diversities of the samples
are estimated from both 16S rDNA sequences (using DNACLUST [42] and RDP-
Classifier [132]) and whole-metagenome shotgun sequences (using MetaPhyler [80]).
Further statistical comparison and principal component analysis revealed that dis-
eased samples share a common structure that was not found in completely healthy
samples, suggesting that the disease state may occupy a narrow region within the
space of possible configurations of the oral microbiome. The computational method-
ologies developed in this paper can be adapted to other metagenomic analysis, e.g.,
the estimation of single nucleotide polymorphism rates and genetic diversity based
on multinomial distribution.
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1.3.5 Chapter 6 - Comparative assembly of metagenomic sequences
So far, one of the biggest challenges in analyzing next-generation sequencing
is the short read length. Although many sophisticated computational tools have
been designed for short reads, the performance is still not very satisfactory in many
applications. All these limitations can be alleviated through metagenomic assembly.
Genome assembly is the process of piecing together short DNA fragments that are
randomly extracted from a sample, to form a set of longer contiguous stretches of
DNA strings called contigs. Assembly, however, is one of the most computationally
challenging tasks in metagenomics, and the contig sizes and accuracy generated from
current tools are far from satisfactory.
We have developed MetaCompass - a comparative metagenomic assembler,
which utilizes the genomes that have already been sequenced, and produces long
contigs through read mapping and assembly. Given the availability of thousands of
existing bacterial genomes, MetaCompass uses taxonomic information to identify a
subset that can be used as appropriate reference set for the data being assembled.
Then, the reads are aligned against these genomes through MUMmer-map (align-
ment algorithm developed by me for this specific task) or Bowtie 2. Afterwards, we
use a greedy algorithm for the minimum set-cover problem to build long contigs.
The consensus sequences are computed by majority rule. We also propose an it-
erative assembly approach to improve the accuracy and contiguity of the resulting
assembly. MetaCompass is the first available comparative assembler for metage-
nomic sequences. It has been evaluated on over 7 Tbp metagenomic sequences,
12
from which we show that, when combined with previous approaches, MetaCompass
significantly improves the overall assembly quality by about 40%.
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Chapter 2
MetaPhyler: Hierarchical Classification of Metagenomic Sequences
MetaPhyler has been published in [80], and an improved version is under
preparation. The methods, algorithms and experiments in this study originated
from discussions between Dr. Mihai Pop and me. I developed the program and
performed the experiments. Dr. Mihai Pop and I write the paper together.
2.1 Introduction - Taxonomic Profiling for Metagenomics
One fundamental goal in metagenomics is to characterize the taxonomic di-
versity of a microbial community - taxonomic profiling. This is usually achieved
by the targeted sequencing of the 16S rRNA gene, either as a whole, or focused
on a hypervariable region within the gene [125]. Then the sequences are classified
based on similarity against a curated reference 16S rRNA database [132]. This ap-
proach has been a powerful research tool allowing biologists to explore the majority
of previously unknown microorganisms populating our world. Approaches based on
16S rRNA sequencing, however, provide a biased estimate of microbial diversity due
to the wide variability in copy number of the 16S gene even within closely related
organisms (Figure 2.1a), and due to amplification biases inherent in PCR.
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(a) Targeted sequencing of 16S rRNA
(b) Metagenome shotgun sequencing
Figure 2.1: Estimating taxonomic profiles using 16S rRNA targeted sequencing or
metagenome shotgun sequencing. Panel (a) shows that the taxonomic profile esti-
mated from 16S rRNA targeted sequencing is biased because of copy number vari-
ation. Panel (b) shows that classification of whole-metagenome shotgun sequences
may produce biased estimation because of the variations in genome size.
A more direct approach for taxonomic profiling is to classify metagenomic
reads through similarity search against a reference genes database. MEGAN [55]
maps query sequences to the NCBI nr database using BLAST, and assigns them
taxonomic labels according to the lowest common ancestor of the top database hits.
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CARMA [66] first searches for conserved Pfam domains and protein families within
the unassembled reads of a sample, then constructs a phylogenetic tree of each
matching Pfam family and the corresponding query reads, and finally the reads are
classified into a higher-order taxonomy depending on their phylogenetic relationships
with respect to the database sequences that have known taxonomic origins. In
contrast to similarity-based approaches, machine learning and statistical methods
[11,86] have been used to classify DNA sequences based on DNA base composition
signatures (usually k-mer frequencies). Further, a hybrid approach PhymmBL [11]
has demonstrated that the combination of machine learning (Phymm) and similarity
information (BLAST) produces higher accuracy than either method alone. Despite
the difficulties in accurately classifying whole-metagenome shotgun sequences, the
estimated taxonomic profiles may be biased because of variations in genome size
(Figure 2.1b).
In this paper, we present a novel taxonomic profiling tool (MetaPhyler) [83]
for metagenomic sequences, which relies on 31 phylogenetic marker genes [136] as a
taxonomic reference. We extend the database described by Wu and Eisen [136] by
including marker genes from all complete genomes, the NCBI nr protein database
and 60 draft genomes. One major limitation of prior methods used in this context is
the use of a universal classification threshold for all genes at all taxonomic levels (e.g.,
BLASTP E-value=0.1 used by AMPHORA [136]). However, individual bacterial
genomes and proteins can have different evolutionary rates, and metagenomic reads
contain gene fragments of different lengths. We propose that better classification
results can be obtained by tuning the taxonomic classifier to the length of each HSP
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(high-scoring segment pairs in BLAST), to the reference gene, and to the taxonomic
level. Our classifier, based on BLAST, uses different thresholds for each of these
parameters, which are automatically learned from the structure of the reference
database. A side-effect, and an important feature of our tool, is the ability to identify
novel organisms or taxa. Results on simulated metagenomic datasets demonstrate
that MetaPhyler outperforms previous tools used in this context (CARMA, Megan
and PhymmBL). Further, MetaPhyler is much faster than previous tools for two
reasons: (1) the size of the reference database is much smaller than the NCBI
nr database; and (2) our classifier based on BLAST bit scores involves much less
computation than some previous approaches which build phylogenetic trees [66,131,
136]. Finally, we present several interesting results obtained by applying MetaPhyler
to the gut microbiomes of obese and lean twins [130].
2.2 MetaPhyler Classifiers
2.2.1 Building a reliable phylogenetic marker genes database
To use metagenomic sequences for taxonomic profiling, we analyzed 31 protein
coding marker genes previously shown to provide sufficient information for phylo-
genetic analysis [136]. These phylogenetic marker genes are universal, present only
once in most genomes, and are rarely subject to horizontal gene transfer. Hence,
they provide a more accurate estimation of the microbial composition than meth-
ods relying on 16S rRNA alone. In order to create an accurate and comprehensive
reference dataset, we used the manually curated marker genes from AMPHORA
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as a seed dataset, and extended them by including marker genes from all complete
genomes, the NCBI nr protein database and 60 draft genomes. Specifically, we first
build MetaPhyler classifiers (see below) on the seed dataset, and then use them
to classify potential marker genes. In addition, we have also included phylogenetic
marker genes from Archaea, whose information is not available in the seed dataset
from AMPHORA. As a result, our final marker genes dataset covers 581 genera, 214
families, 99 orders, 46 classes and 27 phyla.
2.2.2 Building MetaPhyler classifiers
Many previous metagenomic studies employ similarity-based classification meth-
ods, and apply a universal threshold for all genes. The taxonomic label of the best
similarity hit is then transferred to the query sequence. An improved variant of this
approach involves combining the top hits instead of only using the best one [55]. We
propose that better classification results can be obtained by tuning the taxonomic
classifier to each BLAST HSP length, reference gene, and taxonomic rank. Specif-
ically, by learning parameters from the reference database, we build a taxonomic
classifier for a particular reference gene G as follows (Figure 2.2):
1. Simulate 60bp metagenomic reads from all reference marker genes that were
curated as described in the previous section and, as a negative set, from ge-
nomic sequences that do not contain marker genes.
2. Map these simulated reads against reference gene G using BLASTX.
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(1) Simulate 100bp metagenomic reads!
(2) Map simulated reads to gene G using BLAST.!
I(bi < bcut )
bi !Border
" + I(bj # bcut )
bj !Bother
"
(3) Find classification threshold to minimize error function:!
(4) Repeat previous three steps to find cutoffs for longer reads 
and all taxonomic levels.!
(5) Build linear regression at each taxonomic level.!
Figure 2.2: Building MetaPhyler classifier for 60bp long reads of gene G. We first
simulate metagenomic reads from all reference marker genes, and as a negative set,
from genomic sequences that do not contain marker genes. We then map these
simulated reads against reference gene G using BLASTX. To build a classifier for
gene G at a specific taxonomic level, say order, in vector Border we store BLASTX
bit scores between gene G and the simulated reads that are from the same order;
in vector Belse we store bit scores for aligning all other reads against G. We then
find the bit score cutoff bcut that minimizes Equation 2.1. Finally, we repeat the
previous steps to find bit score cutoffs for simulated reads of other lengths and for
other genes.
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3. To build a classifier for gene G at a specific taxonomic level, say order, in
vector Border we store BLASTX bit scores between gene G and the simulated
reads that are from the same order; in vector Belse we store bit scores for
alignments of all other reads against G. Then, we find the bit score cutoff bcut
that minimizes the following error function:
∑
bi∈Border
I(bi < bcut) +
∑
bj∈Belse
I(bj > bcut) (2.1)
where I is an indicator function, which equals 1 when the condition is met, and
0 otherwise. The taxonomic tree used in our analysis is downloaded from the
NCBI taxonomy database, however our analysis can be redone with a different
taxonomic tree.
4. Repeat the previous three steps to find bit score cutoffs for simulated reads of
lengths 120bp, 180bp and up to the length of gene G in 60bp increments.
5. To find cutoffs for sequences of arbitrary matching lengths, we build a linear
regression: bLcut = a+bL (see below for why we choose linear regression), where
L is the sequence length, bLcut is the bit score cutoff for length L, and a and b
are parameters estimated from the data.
6. Repeat steps (3), (4) and (5) to build bit score cutoff regressions for other
taxonomic levels (genus, family, class and phylum) for gene G.
We, then, repeat the above procedures to build classifiers for all reference
marker genes in our database.
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In step (3), we assume that bit scores from close phylogenetic neighbors are
higher than distant neighbors. This is generally true because marker genes, which
are more closely related phylogenetically, tend to have more similar sequences. How-
ever the phylogenetic relationships of the marker genes are not fully consistent with
the corresponding taxonomic tree, which is downloaded from the NCBI taxonomy
database. Ideally we would expect to see the cutoff bcut to be lower than all the
scores in Border, but higher than scores in Belse. The error metric (Equation 2.1) we
used is a count of the number of misclassified points, which is similar to the 2-norm
distance used by SVM classifiers.
Next, we show that in step (5) linear regression is a reasonable approximation
of bit scores based on the matching HSP length. As described in [4], the bit score is
Sbit = (λS − lnK)/ ln 2 (2.2)
where S is the raw score of the BLAST alignment, and λ and K are parameters
depending on the database. In addition, the raw score S equals the sum of the
scores of matching amino acids [4]
S =
∑
Sij = log(qij/pipj) (2.3)
which is the log-odds ratio of the observed and expected frequencies. For gene G of
length L, we can rewrite Equation 3 as S = L
∑
Sij/L. For metagenomic read G
′ of
length L′(L′ ≤ L), which only contains a subsequence of the full-length gene G, the
raw score S ′ = L′
∑
Smn/L
′. Further, if we assume that the evolutionary mutations
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Sij/L = Sij (2.4)
which indicates that S ′ = L′Sij. Hence, we can rewrite equation 2.2 for a gene
fragment as
S ′bit = (λL
′Sij − lnK)/ ln 2 (2.5)
where Sij is a constant for a particular gene G. As a result, the bit score (S
′
bit) of a
subsequence of gene G is linearly correlated with the HSP length (L′), and we can
estimate this relationship with a linear regression as in step (5).
2.2.3 Classifying metagenomic sequences
The query metagenomic sequences are initially mapped to the reference marker
genes using BLASTX. MetaPhyler classifies each sequence individually based on its
best reference hit. For example, assume that a query sequence Q has gene G as its
best hit, the BLAST bit score is b and the HSP length is L. First we try to classify
Q at the genus level by calculating the bit score cutoff bcut of gene G using the
pre-computed linear regression function. If the bit score is higher than the cutoff
(b ≥ bcut), then we transfer the genus label of reference G to query Q. Otherwise, we
try to classify Q at higher taxonomic levels (family, order, class and phylum) using
level-specific classifiers built for gene G, until either the classification is successful
at one of the taxonomic levels or the query can not be classified.
A side-effect of this algorithm, specifically the stringent classification strategy
that can avoid assigning an organism to a lower-level taxonomic group if the evi-
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dence does not support this assignment, is the ability to identify novel organisms
or taxa. The presence of novel organisms leads to a detectable discrepancy between
the number of sequences assigned to a lower taxonomic level, and the number of
sequences assigned to a higher (less specific) taxonomic level. For example, if a set
of query sequences are classified into a particular order, but cannot be classified into
any existing families under this order, then this indicates that these reads come from
novel family-level clades. These sequences can be further analyzed using a de novo
approach, e.g., using Minimus [120], which will potentially recover the full-length
gene and, thus, help characterize the novel bacterium. In order to help the users
easily identity novel bacteria from MetaPhyler output, we used the following naming
rule for example: if a sequence is classified at the family level as Enterobacteriaceae,
but can not be classified to any genera under it, then we name this sequence as
Enterobacteriaceae{family} at the genus level.
2.2.4 Estimating bacterial composition
After taxonomic classification of phylogenetic marker genes from metagenomic
sequences in the previous step, for each taxonomic unit, we have a set of reads as-
signed to each phylogenetic marker gene. The depth of coverage of this taxonomic
unit is calculated as the median of that of the 31 phylogenetic marker genes. Then
the relative abundances of all taxonomic units are computed using the depth of
coverage instead of the number of reads classified. Table 2.1 shows an example of
MetaPhyler output at the genus level for the simulated metagenomic sample in Ta-
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ble 2.
Genus Coverage Abundance # Reads Mapped
Bifidobacterium bifidum PRL2010 24.98 49.97% 3765
Bacteroides fragilis NCTC 9343 10.19 20.37% 1806
Staphylococcus aureus USA300 5.12 10.24% 879
Enterococcus faecalis V583 5.03 10.06% 823
Clostridium difficile 630 4.68 9.36% 748
Table 2.1: An example of MetaPhyler output.
2.2.5 Customized training and classification confidence score
The previous version of MetaPhyler (described above) is specifically designed
for taxonomic classification of phylogenetic marker genes. The hierarchical classi-
fication algorithm, however, is applicable to all homologous biological sequences or
genes. In this section, we describe the second version of MetaPhyler with the fol-
lowing two new features: (1) allow users to train their own MetaPhyler classifiers,
given a set of training data set which includes homologous sequences and their hier-
archical labels; (2) instead of calculating a classification threshold during training,
we compute a confidence score for during hierarchical classification.
The training step is performed in about the same way as in Figure 2.2. The
difference is step (3). Instead of finding a classification cutoff that minimizes the
training error rate, we model the distribution of the BLAST similarity scores within
different hierarchical groups using a nonparametric density estimation approach. For
example, in terms of NCBI taxonomy, MetaPhyler will estimate the distribution of
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similarity scores at the genus, family, order, class, and phylum taxonomic groups.
Figure 2.3 shows the distribution of BLAST bit score with different taxonomic
groups for rplB gene. As expected, the scores for lower taxonomic groups are higher
than that for upper ones.

































Figure 2.3: Distribution of BLAST scores within different taxonomic clusters for
rplB genes with 300bp length. 300bp DNA sequences are simulated from available
rplB genes. Density distribution is estimated using Gaussian kernel. On average,
similarity scores from lower hierarchical/taxonomic clusters are higher than that
from upper clusters.
Once we have built the classifiers as described above, to classify a query reads,
we first find its best neighbor through BLAST search. And use the BLAST bit
score and the density distribution we already have for the best neighbor to compute
the confidence score for each hierarchical classification. Specifically, the confidence
score is defined as follows: Given an anonymous query sequence Q, its best neighbor
R is determined by a BLAST search, and the bit score is S. Then we will use the
classifier built for R to classify query Q. The confidence score at a taxonomic level
k is calculated as
confk =
∑k
i=1 Pi(X ≤ S)∑k
i=1 Pi(X ≤ S) +
∑n
j=k+1 Pj(X ≥ S)
(2.6)
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where Pi(X ≤ S) represents the probability of observing a score that is less than
or equal to S in the estimated density distribution at taxonomic level i. n is the
total number of taxonomic levels for R. The taxonomic levels are ranked as 1 to k
starting from leaves to root. Figure 2.4 shows an example about how to compute
the confidence score.

































Figure 2.4: The figure configuration is the same as that in Figure 2.3. Suppose the
alignment score for a query is 500, then the confidence score is computed as the
ratio of red region/(red region + green region).
2.3 Results
2.3.1 Performance evaluation using simulated datasets
We carried out a simulated metagenomic study by comparing MetaPhyler with
three other widely used tools: WebCarma [66], MEGAN [55] and PhymmBL [11].
We have randomly simulated around 300K 60bp and 70K 300bp DNA sequences
from 31 phylogenetic marker genes. Figure 2.5 compares the sensitivity (number of
correct predictions / number of simulated reads) and precision (number of correct
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predictions / number of predictions) of the phylogenetic assignments at five tax-
onomic levels. The query sequence itself was removed from the reference dataset
when running MetaPhyler, MEGAN and PhymmBL. We can see that MetaPhyler,
MEGAN and PhymmBL have comparable precisions in almost all cases, and Meta-
Phyler is a little bit better than others at the genus level. However, the sensitivity
of MetaPhyler is significantly better than other tools in all situations, perhaps due
to the fact that the classifiers are explicitly trained at each taxonomic level. Figure
2.6 and Figure 2.7 show the classification precision and sensitivity for six marker
genes separately. We can see that the variations in performance on different marker
genes are not significant.
One of the major challenges of metagenomic analysis is the presence of novel
DNA sequences which do not match well any data in current databases. One major
goal of metagenomic analysis is to discover and classify such novel sequences. For
example, we asked the following question: given a read from an organism whose
genome has not been sequenced before, and also no sequences from the same genus
are available, can we classify this sequence correctly at the family level provided
that we have sequences from other organisms within the same family? We further
examined the performance of MetaPhyler using progressively less data from organ-
isms related to those from which the query sequences were simulated. Table 2.2
summarizes the sensitivity and precision performance evaluated on 60bp and 300bp
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Figure 2.5: Comparison of phylogenetic classification performance of MetaPhyler,
MEGAN, CARMA and PhymmBL. The sensitivity and precision are calculated
across five taxonomic levels using 60bp and 300bp simulated metagenomic reads.
During the classification with MetaPhyler, MEGAN, and PhymmBL, reference se-
quences that are from the same genome as the query reads are excluded. CARMA
results are from the classifications based on WebCARMA server. This figure shows
that the sensitivity of MetaPhyler significantly outperforms the other three methods,
and that the precision is also slightly better at the genus level.
simulated metagenomic reads. Overall the classification precision is still very high
when fewer reference marker genes are available. This is especially true for the
300bp reads: even if no sequences in the database originate from the same genus
as the query reads, the precision is still higher than 92% when classifying at higher
taxonomic levels.
As we have discussed in the Introduction section, estimating the abundance of




















































































































































































Figure 2.6: Classification precision for six marker genes (rplA, rplB, rplC, rpsB, rpsC
and rpsE) evaluated on four tools (MetaPhyler, PhymmBL, MEGAN and CARMA).
Red bar is MetaPhyler (1st column); blue bar is PhymmBL (2nd column); green
bar is MEGAN (3rd column); purple bar is CARMA (4th column).
is more accurate than that obtained through 16S rRNA analysis or classification of
all of the metagenomic shotgun sequences. In order to validate our hypothesis, we
have created a simple simulated metagenomic sample comprising 5 genomes (Ta-
ble 2.3). We compared the accuracy of the taxonomic profiles estimated by different
approaches (Figure 3). The genomes, which are present in the simulated sample,
are eliminated from MetaPhyler reference database. MetaPhyler outperforms other
approaches dramatically, and is very close to the true taxonomic profile. While for




















































































































































































Figure 2.7: Classification sensitivity for six marker genes (rplA, rplB, rplC, rpsB,
rpsC and rpsE) evaluated on four tools (MetaPhyler, PhymmBL, MEGAN and
CARMA). Red bar is MetaPhyler (1st column); blue bar is PhymmBL (2nd column);
green bar is MEGAN (3rd column); purple bar is CARMA (4th column).
assume that the classification is perfect (“16S Ideal” and “Shotgun Ideal” in Figure
2.8), the resulting taxonomic profile is still highly biased.
2.3.2 Detecting novel organisms
As mentioned in the Introduction (see Methods for details), MetaPhyler can
help to identify novel bacteria from metagenomic sequences. Here we show a con-
crete example based on sample F10T1Ob1 from the above-mentioned human gut
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Exclude 60bp 300bp
Training Genus Family Order Class Phylum Genus Family Order Class Phylum
Genome 90.72 97.18 98.10 99.11 99.56 97.90 99.14 99.15 99.34 99.64
33.45 54.22 59.59 70.72 75.30 52.39 70.17 78.09 84.52 91.18
Genus 77.15 86.32 94.92 96.72 92.55 95.71 98.23 98.84
16.47 23.16 34.60 43.48 31.06 48.63 64.22 77.35
Family 63.62 90.31 94.65 85.25 96.78 97.66
13.19 24.64 34.99 26.65 53.15 69.42
Order 80.04 90.29 93.69 96.26
17.73 27.80 39.97 58.86
Class 78.16 90.94
16.59 42.62
Table 2.2: MetaPhyler performance using fewer and fewer training dataset. Meta-
Phyler phylogenetic classification performance on 60bp and 300bp simulated metage-
nomic reads. For each prediction, the top and bottom numbers are precision and
sensitivity in percentage, respectively. Different taxonomic levels are excluded when
evaluating the classification, e.g., ‘Genus’ means genes that have the same genus
label as the query read are excluded from the reference training dataset.
Species Coverage Abundance Genome Size # 16S rRNA
Bifidobacterium bifidum PRL2010 25 50% 2.2Mbp 3 copies
Bacteroides fragilis NCTC 9343 10 20% 5.1Mbp 6 copies
Staphylococcus aureus USA300 5 10% 2.8Mbp 5 copies
Enterococcus faecalis V583 5 10% 3.2Mbp 4 copies
Clostridium difficile 630 5 10% 4.2Mbp 11 copies
Table 2.3: Simulated metagenomic sample. To evaluate the performance of different
approaches in estimating the bacterial composition, we have created a simulated
metagenomic sample consisting of 5 species with 100bp reads. ”Coverage” indicates
the depth of the coverage of the simulated reads in the simulated sample for the
genomes.
metagenome dataset. We have identified a set of reads belonging to the order
Clostridiales, but novel at the family level. We then used Minimus [120] to assemble
9 reads that are mapped to the rplB gene. One of the resulting contigs (comprising 5
reads) contained the full-length rplB gene. We searched the contig against the NCBI
nr database and identified as the best hit the rplB gene from species Ruminococcus
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Figure 2.8: Comparison of bacterial compositions estimated from different ap-
proaches. We have created a simulated metagenomic sample (Table 2.3) with 100bp
reads to evaluate the performance of different approaches in estimating the bacte-
rial compositions. ”16S Ideal” and ”Shotgun Ideal” represent results obtained by
analyzing 16S rRNA genes and whole genome shotgun sequences assuming the clas-
sification accuracy is perfect. Genus ”Other” indicates that sequences have been
classified into genera other than that in the simulated sample. Different approaches
are ranked by their correlation coefficients (shown in legend) between the estimated
and true taxonomic profile. When running MetaPhyler, the genomes from which
the reads were simulated are removed from the reference database.
sp. SR1/5 with 94% and 86% similarity at the amino acid and nucleotide levels,
respectively. In addition, our assembly of another contig containing a fragment of
rplB gene had 93% and 82% similarity with Blautia hansenii DSM 20583 at the
amino acid and nucleotide levels, respectively. Given the low level of similarity at
the nucleotide level between the genes extracted from the dataset and all previously
characterized genes, we can be fairly confident that the rplB genes we identified
are novel and likely belong to previously unsequenced members of the Clostridiales
order. It is important to note that this discovery was made possible by the stringent
strategy we employ which avoids assigning an organism to a lower-level taxonomic
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group if the evidence does not support this assignment, a feature not available in
other taxonomic profiling tools.
2.3.3 Comparison of running times
We compared the running time of MetaPhyler with three other tools (PhymmBL,
MEGAN and WebCarma) on 70K 300bp simulated phylogenetic marker gene frag-
ments (Table 4). On a single 2.4GHz processor, the running times (including BLAST
search) of MetaPhyler, PhymmBL and MEGAN for analyzing the simulated dataset
are 8 hours, 4 days, and 34 days, respectively. On the same dataset WebCarma [41]
took 24 hours. MetaPhyler is much faster than other tools in estimating the taxo-
nomic compositions from metagenome shotgun sequences.
Dataset
Wallclock hours
MetaPhyler PhymmBL MEGAN WebCarma
70K reads 6 hrs 96 hrs 816 hrs 24 hrs
Table 2.4: Comparison of the estimations of bacterial compositions from different
approaches. On a single 2.4GHz processor, the computation time (Wallclock hours)
used by MetaPhyler, PhymmBL and MEGAN for analyzing 70K 300bp simulated
sequences. CPU hours for WebCarma are calculated using its web server.
2.3.4 Conclusion
We have introduced a novel taxonomic classification method for analyzing the
microbial diversity of metagenomic sequences. Compared with previous approaches,
MetaPhyler provides significantly higher sensitivity when classifying 60bp and 300bp
simulated reads; MetaPhyler has slightly higher classification precision at the genus
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level, and comparable precision at higher taxonomic levels. More importantly, the
taxonomic profiles estimated by MetaPhyler are much more accurate than those
estimated by other tools. In addition, MetaPhyler is much faster than other tools
for taxonomic profiling because (1) the reference marker genes database is much
smaller than a general reference genes database (e.g., the NCBI nr database), (2)
and also our classifier based on BLAST statistics involves much less computation
than building phylogenetic trees (another approach used for taxonomic profiling).
The high performance of MetaPhyler makes it suitable for large scale metagenomic
studies, e.g., the Human Microbiome Project. Furthermore, analysis of publicly
available metagenomic data agrees with previous observations, and also provides
new insights into the microbial diversity of the human gut ecosystem. Finally, we
have demonstrated that MetaPhyler can be used to guide the discovery of novel
organisms from metagenomic sequences.
The novel classification algorithm for short DNA reads we have introduced
in this paper can also be applied to other conserved genes. We are planning to
release a general gene fragment classifier, which can learn classification thresholds
automatically from a user provided dataset. In addition, instead of providing a
binary result for each classification, we will also explore techniques for generating
”fuzzy” classifications based on confidence scores. The software described in this




Comparative Analysis of Metabolic Networks
MetaPath has been published in [84]. The methods, algorithms and experi-
ments in this study originated from discussions between Dr. Mihai Pop and me. I
developed the program and performed the experiments. Dr. Mihai Pop and I write
the paper together.
3.1 Introduction - Functional Signatures in Metagenomics
Metagenomics is a new scientific field that involves the analysis of organismal
DNA sequences obtained directly from an environmental sample, enabling studies
of microorganisms that are not easily cultured in a laboratory [104]. Metagenomic
studies, pioneered in the early 2000s [9], have recently increased in number and
scope due to the emergence of next generation sequencing technologies.
Due to the difficulty of assembling entire organisms from a metagenomic data-
set, most comparative metagenomic analyses take a gene-centric view, treating the
community as an aggregate and ignoring the exact assignment of genes to individual
organisms. In fact, it can be argued that the environment is better characterized
by its gene complement than by its taxonomic composition, given that similar bio-
logical functions can be performed by microbes of distinct taxonomic origins [130].
The functional profile for a sample can be recovered by mapping sequences to gene
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families [123], subsystems [87] or metabolic pathways [61]. The relative abundance
of each functional category can be estimated by counting how many sequences are
assigned to each category, and this information is the basis for detailed compar-
isons of the functional potential of different functions. In a typical comparative
metagenomics experiment, sequences are generated from a collection of samples be-
longing to two groups, for example, obese or lean twins [130], and healthy infants
or adults [69]. An important biological problem is to find differentially abundant
functional signatures (e.g., genes or metabolic pathways) that are selected for by
their local environments.
Traditional analysis approaches compare the relative abundances of the cat-
egories one-at-a-time between different phenotypes, and compute the significance
using one of several statistical approaches [43,107,133]. When comparing communi-
ties at the gene family level, many functional categories are commonly found to be
differentially abundant, even after correcting for multiple hypothesis testing [69,130].
The interpretation of these data can be daunting. An alternative approach focuses
on functional subsystems and metabolic pathway comparisons [126], the number
of which is much smaller than gene families. Results at these levels are easier to
interpret and can provide a stronger evidence of distinct functional capacities than
at the level of individual gene families. Such analyses, however, can be unneces-
sarily coarse. For example, the use of KEGG pathways as a basis for analysis is
complicated by the following issues: (1) the definitions of pathways in KEGG are
coercive, and the interactions between these pathways are ignored; (2) the genes
in a pathway may not be fully covered by the identified genes in a metagenomic
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sample; (3) significant differences in the abundance of certain genes may be masked
once the abundance of all genes in a pathway is aggregated.
To address these problems, we introduce a general method (MetaPath) for
searching the global metabolic network to find differentially abundant finer-level
subnetworks. For the purposes of this paper we define a subnetwork to be a con-
nected set of genes that is statistically enriched or depleted in one group of samples.
Underlying our approach is a statistical scoring system that captures the differen-
tial abundance for a given subnetwork, combined with a greedy search algorithm
for a maximum weighted subgraph, to indentify the highest scoring subnetworks.
Unlike previous approaches, MetaPath explicitly searches significant subnetwork in
the global metabolic network (rather than the KEGG defined pathways), enabling
us to detect subnetworks spanning predefined “containers”. In addition, we devel-
oped rigorous statistical methods that take into account the topology of the network
when testing the significance of the subnetworks.
Using simulated datasets, we demonstrate that Metapath outperforms previ-
ously described approaches for comparing biological networks based on abundance
data. We show that our findings are more robust to noisy data than the results of
single gene comparisons, and that MetaPath can find finer-level subnetwork than
can be found by comparing predefined KEGG pathways. We also discuss the bio-
logical significance of the results derived from the application of MetaPath to actual
metagenomic datasets, demonstrating that the output from MetaPath is easy to
interpret and provides valuable biological insights. The software is freely available
at http://cbcb.umd.edu/ boliu/metapath/.
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3.2 Methods and Materials
3.2.1 Datasets
We tested our methods on two previously published metagenomic datasets,
which were downloaded from the NCBI Trace Archive or Short Read Archive databases:
(1) gut microbiomes from obese and lean twins [130]; (2) metagenomes from adult-
and infant-type gut microbiomes [69]. Each dataset is divided into two populations
of distinct phenotypes. The metabolic pathway data were downloaded from the
KEGG pathways database [61]. The metabolic network is represented as a graph
where nodes are metabolic substrates, and edges are molecular reactions (Figure
3.1). The edges could be unidirectional or bidirectional depending on whether the
corresponding reaction is reversible (as specified in KEGG database). Multiple
reactions that are related to a same biological process are aggregated by KEGG
into a “pathway” (e.g., glycolysis pathway). In addition, we refer to the network
comprising all metabolic pathways in KEGG as the “global metabolic network”.
Metagenomic sequences are annotated through BLASTX searches against KEGG
genes database. The abundance of each molecular reaction is estimated as the num-
ber of metagenomic sequences mapped to it. Note that more accurate abundance
estimates can be obtained by taking into account the length of individual genes [117]
and we plan to explore the use of such estimates (and the associated statistics) in
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Figure 3.1: Schematic diagram of MetaPath methods. Sequences are annotated
against KEGG database and are mapped to metabolic network leading to an abun-
dance matrix where the rows are different reactions and columns are samples. Then
p values are computed for all reactions using Metastats [133], and are converted into
Z values, then greedy search is performed to find subnetworks with high weights.
Finally, we estimate the null distribution of the subnetwork score by randomly per-
muting the sample labels, and compute the p values.
3.2.2 Scoring Metabolic Subnetworks
To score the biological activity of a particular subnetwork, we first use Metas-
tats [133] to calculate the significance of differential abundance for each reaction
between two groups. Under the null hypothesis, the relative abundances are ran-
dom and have the same distribution across phenotypes, thus the p values follow
a uniform distribution from 0 to 1. Based on this assumption, p values can be
converted to Z scores [56]. Because Metastats performs a two-tailed test for each





CDF−1sn (1− pi/2)×−1 , if mean(G1) < mean(G2)
CDF−1sn (1− pi/2) , if mean(G1) > mean(G2)
(3.1)
CDF−1sn is the inverse cumulative density function of standard normal distribution;
G1 and G2 represent populations 1 and 2. Using this formula, if a reaction is more
abundant in population G1, then its Z score will be positive and vice versa. We are
specifically interested in finding a network whose reactions are either enriched or
depleted as a whole, as apposed to previous approaches [28, 56] that identify active
or perturbed subnetworks, which may contain a mixture of enriched and depleted
components. We define the aggregate score for a particular subnetwork to be the




3.2.3 Identifying High-Scoring Subnetworks
We attempt to find networks that maximize the cumulative Z-score defined
above. Unfortunately, this problem is NP-hard, equivalent to finding a maximum-
weight subgraph [56]. Several approaches to solving this problem have been previ-
ously proposed: [56] used simulated annealing, but this heuristic is slow; [28] used
integer linear programming that can find provably optimal subnetworks quickly, but
it requires the commercial software CPLEX which is not available to the general pub-
lic (re-coding this algorithm using other freely available ILP solvers is beyond the
scope of this paper). Here we rely on a greedy heuristic that is fast, and, while not
guaranteed to find maximally scoring networks, performs well in practice (Algorithm
1).
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Algorithm 1 Searching Max-Weight Subnetwork with a Greedy Heuristic
Input: A global metabolic network G = (V,E), where V and E are metabolites
(vertices) and reactions (edges); a set of weight values Z associated with each edge
in graph G.
Output: A max-weight subnetwork Gmax of G and its score Wmax.
1: Initialize Wmax to 0;
2: for all edge ei in E do
3: Initialize Gnow by including ei;
4: Initialize Wnow to be the weight of ei;
5: Initialize Wpre to be 0;
6: while Wnow ≥ Wpre do
7: Wnow = Wpre;
8: Pick an edge ek which has the highest weight among all edges adjacent to
Gnow;
9: Include ek into Gnow;
10: Calculate the score Wnow of Gnow;
11: end while
12: Wnow = Wpre;
13: Gnow = Gnow − ej;
14: if Wnow > Wmax then
15: Wmax = Wnow;
16: Gmax = Gnow;
17: end if
18: end for
19: Output Gmax and its score Wmax
This algorithm tries to find a connected metabolic subnetwork, which can
have any arbitrary structure, with maximum weight. However, it is believed that in
metabolic networks, chains are especially more biologically meaningful and interest-
ing, because they attempt to capture the structure of a series of reactions that are
successively connected. To allow this idea, we modify line 8 of the above algorithm
to Pick an edge ek which has the highest weight of the edges that are adjacent to
and have the same direction with ek−1. Both searching algorithms are implemented
in our program and can be selected through command-line parameters. To find all
significant subnetworks (computing significance is discussed below), we iteratively
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remove the edges in the global network that are contained in previously found sig-
nificant subnetworks, and rerun our greedy search on the rest of the network until
we can no longer find any additional significant subnetworks.
This algorithm tries to find a connected subnetwork with k edges, which can
have any arbitrary structure. However, it is believed that in metabolic network,
chains are especially more biologically meaningful and interesting, because they
attempt to capture the structure of a series of reactions that are successively con-
nected. To allow this idea, we modify line 5 of the above algorithm to Pick an edge
ej which has the highest weight of the edges that are adjacent to and have the same
direction with ej−1. Both searching algorithms are implemented in our program. In
addition, we also compute the top m high-scoring subnetworks by iteratively remov-
ing the edges in the graph associated with subnetworks already considered by our
algorithm.
3.2.4 Computing the p Values of Significance
The null score distribution for a specific subnetwork can be estimated by per-
muting the sample labels (columns of the abundance matrix) of the reactions and
computing the subnetwork scores from the permuted abundance matrix. The sig-
nificance p value is estimated as the number of random permutations that produce
higher scores than the original subnetwork. The p value computed through this
approach (termed pabund), however, ignores the topology of the underlying global
metabolic network, and potentially leads to incorrect conclusions. For example,
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assume we have a densely connected metabolic network, in which every edge is con-
nected with all other edges. Then, the best subnetwork is simply composed of the
top differentially abundant metabolic reactions. This indicates that whenever there
are significant reactions, which may simply come from random noise given the large
number of edges, they will form a significant subnetwork because of the biases from
the network topology (Figure 3.2). To address this problem, we compute another
p value (termed pstruct), relying on a topological definition of the null distribution
of subnetwork scores. Specifically, instead of treating each subnetwork as a bag of
genes, we estimate the distribution of scores for actual subnetworks identified within
the underlying global metabolic network. Since this null-distribution depends on the
size (number of edges) of the subnetwork, let k be the size of a subnetwork gener-
ated by the greedy search algorithm described above, and Z be the corresponding
Z-score. The pstruct value for this subnetwork can be calculated as follows:
1. Permute the edge weights (row labels of the abundance matrix) of the global
metabolic network.
2. Perform greedy search to find a maximal weighted subnetwork of size k.
3. Repeat step 1 and step 2 for 1000 times, and generate 1000 weights of the
max-weight subnetwork (null distribution).
4. The pstruct value is the proportion of the 1000 permutations in step 3 that we








Fat edge Correlated noise
Figure 3.2: Significant subnetworks caused by structural biases. On the left side,
the two pathways have equal weight, indicating equal statistical significance. The
high weight of the second pathway, however, mainly comes from the middle fat edge.
On the right side, in a densely connected network, any random high-weight edges
will form a subnetwork with high weight (correlated noise).
3.2.5 MetaPath Methods Summary
To summarize the methods described above, the MetaPath algorithm proceeds
as follows:
1. Differential abundance is assessed on an edge-by-edge basis (reaction-byreaction)
using Metastats.
2. The significance estimates (p values) from Metastats are fed into a greedy
search algorithm to determine all maximally weighted subnetworks(in terms
of statistical Z scores) in the global metabolic network.
3. The significance of each subnetwork detected by the greedy search algorithm is
assessed using both a topology-independent bootstrapping approach (pabund),
and a topology-dependent bootstrapping approach (pstruct).
4. The subnetworks determined to be significant (pabund ≤ 0.05 and pstruct ≤ 0.05)
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are reported to the user (Note: the threshold for significance can be adjusted
through command-line parameters). The pathways are ranked by pabund values.
3.3 Results
3.3.1 Performance Evaluation Using Simulated Datasets
In order to validate our methods, we have designed a simulated metagenomic
study and compared the results with three previous approaches: (i) identifying ac-
tive subnetworks using simulated annealing and greedy search [56]; (ii) discovering
significant individual reactions using Metastats [133]; and (iii) finding differentially
abundant KEGG defined pathways, an approach widely used in metagenomic func-
tional comparison [43, 69, 130]. We choose these tools because they are addressing
similar biological problems. However they do not exactly solve the problem in this
paper, which is finding differentially abundant pathways. Here the goal of this sim-
ulated study is to show that our problem can not be solved by directly applying
methods previously developed in a related context.
We designed a simulated metagenomic study in which five subjects are created
for each of the two groups with distinct phenotypes. To generate the artificial
reaction abundance matrix (where rows represent reactions and columns represent
subjects), for each reaction a normal distribution is created, whose mean is randomly
chosen from real metagenomic datasets (obese and lean twins in our study). The
variance is calculated by setting the relative standard deviation (standard deviation
divided by the mean) to 0.2. If we define a reaction to be equally abundant between
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two populations, then a random abundance value is generated from the same normal
distribution for each subject. Otherwise, if a reaction is defined to be significantly
enriched in one population, then another normal distribution is created for this
reaction by increasing the mean such that the p value of the t-test for the two
distributions is less than a predefined value (0.05 and 0.01 were used in our study).
In this study, we have chosen a series of reactions (length 5 or 10) to be enriched
in one population. The goal is to compare different methods in recovering these
significant reactions based on the simulated abundance matrix. Biologically, the
enriched pathways indicate functional enrichment of certain biological processes in
a microbial community.
The receiver operating characteristic (ROC) curve is plotted for each method
(Fig. 3.3). MetaPath outperforms all other methods dramatically showing the ad-
vantage in finding small significant subpathways. The most commonly used ap-
proach – comparing KEGG defined pathways – performs the worst in our simulation
study (Fig. 3.3).
3.3.2 Comparing Obese and Lean Gut Metagenomes
We used MetaPath to compare the abundances of the metabolic networks of
the gut microbiome in lean and obese subjects, relying on data from [130]. This
metagenomic dataset comprises 6 samples from obese subjects and 6 samples from
lean objects. The sequences are annotated and mapped to KEGG reactions using
BLASTX (E value < 10-5, bitscore > 50, and %identity > 50), resulting in total
46












































































































































































Figure 3.3: Comparison of statistical methods of discovering significant reactions
in simulated datasets. Four methods are evaluated: discovering active subnetworks
using simulated annealing (Anneal) and greedy search (Greedy) [56], discovering
significant individual reactions using Metastats [133], finding differentially abundant
KEGG-defined pathways (KEGGPath), and MetaPath. Four datasets are created
by varying the number of significant reactions n and their significance value p.
1832 unique reactions within the 12 metagenomic samples. First, we computed p
values and q values using Metastats to find differentially abundant reactions. Using
a p value cutoff of 0.05, 92.7±9.1 (meanstandard deviation) reactions are signifi-
cant including 37.1±6.6 and 55.6±3.1 enriched reactions in obese and lean groups,
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respectively, based on 10 runs of Metastats. The high variance of the number of
significant genes can be primarily explained by two reasons: (1) some reactions are
slightly below or above significance (0.05), thus p values computed through boot-
strapping will jump between being considered significant and nonsignificant (Figure
3.4); (2) there are large variances of the abundance values within individuals in a
same phenotypic group. In addition to p values, Metastats also provides an estimate
of the False Discovery Rate (q value), information that is not used by MetaPath.The
q values for all reactions are 1 (except R01676 where q=0.73), i.e. a literal inter-
pretation of Metastats results would indicate no pathways are significantly different
between the two populations. This result can be explained by the flat distribution
of the p values (Figure 3.4), from which the q values are estimated. This observation
highlights the limitation of relying on the false discovery rate, which requires the
estimation of the proportion of features that are truly null [122], approach that does
not perform well when only few features are truly significant.
We, then, applied MetaPath to this dataset, and have found 9 differentially
abundant subnetwork (Figure 3.5) using 0.05 cutoff value for both pabund and pstruct.
All these subnetworks are enriched in obese subjects; none was found to be enriched
in lean subjects. These 9 significant subnetworks contain 48 unique reactions, 22
of which are significant. It is worth pointing out that the number of significant
reactions varies between different runs of statistical permutations (using Metastats)
as shown above, but the significant pathways identified by Metapath stay the same
(Figure 3.5). This observation confirms that the results from MetaPath are more
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Comparing metabolic reactions
























Figure 3.4: p values distributions from comparing individual metabolic reactions by
Metastats and from comparing metabolic networks by MetaPath. The top histogram
is the distribution of the p values of individual metabolic reactions calculated by
Metastats. The Bottom histogram is the distribution of the pabund values of the
subnetworks calculated by MetaPath.
robust in the presence of noise in the data than the gene-by-gene approach. In
the p values distribution of subnetworks (Figure 3.4), most of them are either very
significant or insignificant and very few are around the p value cutoff, allowing the
users to easily interpret the results.
Five subnetworks (Figure 3.5a-3.5e) are completely contained in the KEGG
Fatty Acid Biosynthesis pathway, which consists of catabolic processes that can gen-
erate energy and primary metabolites from fatty acids. Our findings are consistent
with previous observations and biochemical analysis in microbiota transplantation
experiments in germ-free mice [129], where the concentrations of short-chain fatty







































































































































































































































































































     pstruct=0.018
(e) pabund=0.004





     pstruct=0.006
(i) pabund=0.002
    pstruct=0.022
(h) pabund=0.004
     pstruct=0.016
Figure 3.5: 9 statistically significant subnetworks are found in the comparison of
the gut microbiome from the obese and lean subjects. All these subnetworks are
enriched in the obese subjects. pabund and pstruct significance values are shown above
each subnetwork. p values for each reaction are shown with the KEGG reaction
number. Five pathways (a)-(e) belong to the Fatty Acid Metabolism pathway in
KEGG. Four pathways (f)-(i) contain the L-Homocysteine molecules.
50
microbiome in obese subjects has an increased capacity for dietary energy harvest.
Another interesting significant subnetwork consists of 10 reactions (Figure
3.5f), of which 8 belong to Cysteine and Methionine Metabolism and 2 belong to
Sulfur Metabolism. Many reactions in this subnetwork are connected by the L-
Homocysteine molecule. In addition, three other subnetworks (Figure 3.5g-Figure
3.5i) we discovered further confirm its potential involvement in obesity, because all
these three pathways contain Lhomocysteine as metabolite. It is well-known that a
high level of blood serum homocysteine is a risk factor for cardiovascular disease [40],
and obesity - an increasingly prevalent metabolic disorder - is closely associated with
heart disease [30]. Significant correlations between plasma homocysteine concentra-
tions and obesity have been previously reported [51, 88]. The finding of increased
potential for homocysteine metabolism within the obese gut microbiome provides an
interesting hypothesis for future studies that, the gut microbiome may either have a
direct role in the elevation of homocysteine levels in plasma, or may indirectly affect
the hepatic biosynthesis of this amino-acid in the human body.
3.3.3 Comparing Infant and Adult Gut Metagenomes
A second data-set comprises gut microbiome samples from 4 infants and 9
adults individuals which were sequenced by [69]. The sequences were annotated and
mapped to the reactions of KEGG pathway using BLASTX (E value < 10-8, hit
length coverage ≥ 50% of a query sequence), resulting in total 1781 unique reactions.
Based on 10 runs of Metastats, 383.7±1.56 reactions are significant using p value
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cutoff of 0.05 and 167.2±2.7 reactions are significant using a q value cutoff of 0.05.
including 268.7 ± 1.56 and 115 ± 0 reactions enriched in infant and adult subjects
respectively. Using a q value cutoff of 0.05, 167.2 ± 2.7 reactions are significant,
including 133.2 ± 2.7 and 34 ± 0 reactions enriched in infant and adult subjects
respectively. Compared with the previous dataset (obese and lean twins samples),
the predictions of significant reactions are much more consistent across different
permutations.
Applying MetaPath to search for significant subpathways, we have found 6 sub-
pathways (Fig. 3.6a-3.6f) enriched in infant subjects and 4 subpathways (Fig. 3.6g-
3.6j) enriched in adult subjects. These 10 significant subpathways contain 55 unique
reactions, including 38 significant reactions and 17 reactions not found significant
by Metastats. Three subpathways (Fig. 3.6a,c,d) enriched in infant subjects in-
volve the metabolite L-homocysteine, which is consistent with previous observation
that breastfed babies have an higher plasma homocysteine level possibly caused by
suboptimal availability of folate in breast milk [39]. The concentration of folate is
negatively correlated with that of homocysteine, as folate is a necessary coenzyme
for reactions that metabolize homocysteine. In addition, babies normally have high
protein diet, which may also cause the concentration of homocysteine to increase. A
second pathway in Fig. 3.6e involves substrates citrate and succinate, and is closely
related with oxidative tricarboxylic acid (TCA) cycle. TCA cycle is part of carbo-
hydrate metabolism and can convert carbohydrates into usable energy in aerobic
organisms. Because the adult gut ecosystem is dominated by strict anaerobes, it
is reasonable to find this subpathway enriched in infant individuals where the gut
52
microbiota also includes aerobes. This finding is consistent with results obtained
by comparing COG functional categories [69]. We also find a subpathway Fig. 3.6f
belonging to atrazine metabolism to be enriched in infant subjects. Atrazine is one
of the most widely used herbicides, and it contaminates water and soil throughout
the world. Our finding possibly indicates a side-effect of this contamination.
The pathway in Fig. 3.6i (enriched in adult subjects) is part of the lipopolysac-
charide biosynthesis. Lipopolysaccharides are a building block of the outer mem-
brane of Gram-negative bacteria. The enrichment of pathway Fig. 3.6i in adult
subject may be a result of the fact that Gram-negative bacteria are also enriched
in adults. Specifically, Bacteroides, a genus of Gram-negative bacteria, are a major
constituent of adult gut microbiome, but not highly prevalent in infants. Fig. 3.6h
and Fig. 3.6j (enriched in adult) are pathways related with pyrimidine metabolism.
The metabolites RNA, cytidine and uridine, which are contained in pyrimidine
metabolism, are normally obtained from high RNA food such as organ meats, broc-
coli, and brewers yeast, which are not available to unweaned infants, as they are not
present in high abundance in milk. The pathway in Fig. 3.6g (enriched in adult)
is part of fructose and mannose metabolism a pathway related to carbohydrate
metabolism. This is also consistent with COG-based analyses indicating that many
mono- or disaccharides metabolism genes are enriched in adults [69], explained by
the fact that colonic microbiota in adults uses indigestible polysaccharides as re-





































































































































































































































     pstruct=0.038
(c) pabund=0.002





     pstruct=0.040
(f) pabund=0.002
    pstruct=0.018
(g) pabund=0.002
     pstruct=0.002
(i) pabund=0.002
    pstruct=0.022
(h) pabund=0.004
     pstruct=0.016
(j) pabund=0.002
    pstruct=0.030
Figure 3.6: 10 statistically significant subpathways are found in the infant and adult
individuals dataset. 6 subpathways are enriched in the infant subjects (a)-(f), and 4
subpathways are enriched in the adult subjects (g)-(j). pabund and pstruct significance




We have introduced a statistical method for finding significant metabolic sub-
pathways from metagenomic datasets. Compared with previous methods, results
from MetaPath are more robust to noise in the data, and have significantly higher
sensitivity and specificity (when tested on simulated datasets). When applied to
two publicly available metagenomic data-sets the output of MetaPath is consistent
with previous observations and also provides several new insights into the metabolic
activity of the gut microbiome. Finally, MetaPath is efficient: a typical metage-
nomic dataset and the corresponding metabolic network (about 2000 edges) can be
analyzed in half an hour on a single processor.
While showing promising results, our methods have several limitations that
we plan to address in the near future. First, and foremost, we restrict ourselves to
pathways of a fixed length a restriction necessary for accurately computing the null
distribution of pathway scores. This can severely affect our ability to discover long
pathways whose abundance differs only slightly, but significantly, between samples.
Second, we currently estimate gene abundances by simply counting the number of
sequencing reads that map to a certain gene. Such an approach ignores differences in
the length of genes, potentially leading to incorrect conclusions. We plan to address
this issue by incorporating a recently-published [117] method that can accurately
correct for genelength effects. The software described in this paper is freely-available
under an opensource license from http://cbcb.umd.edu/ boliu/metapath/
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Chapter 4
Antibiotic Resistance Genes Database
ARDB has been published in [81]. The methods, algorithms and experiments
in this study originated from discussions between Dr. Mihai Pop and me. I devel-
oped the program and performed the experiments. Dr. Mihai Pop and I write the
paper together.
4.1 Introduction
The discovery of penicillin in 1928 by Alexander Fleming has revolutionized
the treatment of bacterial infections. The large-scale use of antibiotics, however,
has also led to an increase in the number of microbes that can resist treatment.
Drug resistant bacteria are an increasing threat to public health, as highlighted
by a recent estimate that in the US methicillin-resistant Staphylococcus aureus
(MRSA) may contribute to more deaths than HIV [5]. Methicillin-resistant strains
of S. aureus were initially documented in the 1960s [6] and have been associated
with higher mortality rates [26,114] than their drug-sensitive counterparts. Similar
challenges are posed by the emergence of multidrug- and extensively-drug resistant
tuberculosis (MDR-TB and XDR-TB, respectively) [113]. Antibiotic resistance can
result from large genomic changes, such as the acquisition of entire plasmids or
mobile elements encoding resistance factors. Recent studies are, however, revealing
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the important role small mutations play in the evolution of resistance. For example,
only 35 point-mutations distinguish a vancomycin-resistant strain of S. aureus from
its sensitive counterpart, and these mutations evolved in just 3 months within an
infected patient [89]. Furthermore, antibiotic resistance genes have the potential to
be used for bioterrorism purposes through genetically modified organisms. These
factors emphasize the urgent need for a better understanding of the mechanisms
through which bacteria develop resistance, as well as for the development of new
techniques for the rapid identification of resistance factors. The database presented
in this article provides a first component of an informatics infrastructure aimed at
enabling such studies.
Several mechanisms have been characterized through which bacteria become
resistant to antibiotics [2]: (i) the production of enzymes that digest/metabolize the
antibiotic; (ii) efflux pumps that eliminate the drug from the cell; (iii) modifications
to the cellular target of the antibiotic that prevent binding; (iv) activation of an
alternate pathway that bypasses drug action; and (v) particularly for gram-negative
bacteria, down-regulation or elimination of transmembrane porins through which
drugs enter the cell. The annotation information commonly associated with genes
deposited in public databases is insufficiently detailed for representing this variety
of resistance mechanisms and the additional meta-information relevant in this con-
text. Specifically, each resistance gene is associated with a resistance profile (set
of antibiotics or classes of antibiotics targeted by the gene), yet this information is
usually not available. Second, resistance often requires the cooperation of multiple
genes, usually within a same operon (e.g. vancomycin resistance VanA operon re-
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quires seven genes [23]), while most annotation information is targeted at individual
genes. Finally, resistance frequently results from modifications to, or the disruption
of an individual gene (e.g. modifications of the drug target), information incompat-
ible with standard annotation procedures. Consequently, specialized resources are
necessary for annotating and cataloging information related to antibiotic resistance.
Several recent efforts have been made to partially unify this information, such
as Antibiotic Resistance Genes Online (ARGO) [111], MvirDB [140] and a com-
pendium of TEM β-lactamase genes at the Lahey Clinic (www.lahey.org/Studies/).
All, however, have limited functionality. ARGO only contains part of β-lactamase,
vancomycin and tetracycline resistance genes. In addition, it does not include rich
annotation information such as resistance profile, mechanism of action, operon in-
formation or gene sequence. Furthermore, many of the links between ARGO and
GenBank target incorrect records (e.g. links to a genome instead of the relevant
gene record). MvirDB is a broad repository of virulence-associated genes, including
toxins, virulence factors and antibiotic resistance. The latter information is simply
a replicate of the ARGO database. The Lahey Clinic website is a comprehensive
collection of TEM type β-lactamases, which attempts to standardize the nomencla-
ture for these genes. In addition to these specialized resources, antibiotic resistance
information can be extracted in a restricted manner from GenBank and SwissProt,
databases that lack many important types of information relevant in this domain.
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4.2 Database contents and construction
To address the limitations of currently available public resources, and to fa-
cilitate the identification and characterization of antibiotic resistance genes, we
have created a manually curated database (Antibiotic Resistance Genes Database
(ARDB)) unifying most of the publicly available genes and related information.
Our motivations in creating ARDB are (i) to provide a centralized compendium
of information on antibiotic resistance; (ii) to facilitate the consistent annotation
of resistance information in newly sequenced organisms; and (iii) to facilitate the
identification and characterization of new genes. We believe this resource will be
found useful by a broad range of scientists, including microbiologists, clinicians and
the bio-defense research community.
The diversity of antibiotic resistance genes, types and mechanisms, combined
with the fact that related information, such as resistance profile, is mostly ‘paper-
bound’ made the construction of ARDB both difficult and time-consuming. To
compile, confirm and validate this collection of data, several textbooks and several
hundred journal articles were searched and summarized.
The majority of protein and nucleic acid sequences of known antibiotic resis-
tance genes were retrieved from the NCBI nucleotide and protein databases and
additional sequences were retrieved from the Swiss-Prot database. Genes were
grouped into resistance types based on their protein sequence similarity using the
following approach. First, the sequence of an experimentally confirmed represen-
tative was identified for every type of resistance, based on literature searches and
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meta-information provided by the NCBI protein database. These representative
resistance genes were then used to fish out additional homologues using similarity
searches against the NCBI nr database. The similarity cutoff was set at 80% unless
a different value was recommended in the literature for a specific resistance type.
Using this approach we identified 13 254 protein sequences putatively involved in
antibiotic resistance. We filtered this set by removing vector sequences, synthetic
constructs and redundant genes, resulting in a non-redundant set of 6206 proteins.
This set was further refined by removing incomplete sequences, thereby yielding a
core set of 4554 antibiotic resistance proteins. Each sequence was associated with
corresponding CDD, COG, ontology and source organism information. Furthermore,
the genes were grouped into resistance types, corresponding to clusters of genes with
similar resistance profiles, operon membership and mechanism of action. In addi-
tion, basic information about known antibiotics was extracted from KEGG DRUG,
PubChem, PubMed MeSH database and the Chemical Entities of Biological Inter-
est (ChEBI) ontology. Although ARDB is mainly targeted at antibiotic resistance
genes, 12 additional drug targets have also been included into ARDB with relevant
information (16S rRNA (16), 23S rRNA, gyrA (17), gyrB, parC, parE, rpoB, katG,
pncA, embB, folP, dfr), whose modification has been shown to confer resistance.
The data flow for the curation process is highlighted in Figure 4.1. ARDB is
implemented as a MySQL relational database. Access to this database is provided





































Figure 4.1: ARDB pipeline, including the construction process and the services
provided. The initial seed genes are manually curated from published literature.
4.3 Ontology information
No comprehensive ontology is currently available for annotating antibiotic re-
sistance information. To facilitate the computational analysis of antibiotic resistance
information we have created a set of ontology terms aimed at characterizing both
the resistance profile conferred by a specific gene and its specific mechanism of ac-
tion. Specifically, for every antibiotic X, we have created a set of X resistance terms.
Furthermore, we classify several mechanisms of action, including drug target modi-
fication, replacement or protection, drug enzymatic destruction and drug transport.
Drug transport is further subclassified into ATP-binding cassette (ABC) drug efflux,
major facilitator superfamily (MFS) drug efflux, small multidrug resistance (SMR)
drug efflux and resistance-nodulation-cell division (RND) drug efflux, following the
terminology used in [49]. These terms are defined within an Antibiotic Resistance
(AR) ontology and are associated with each record present in our database. We
are currently working with the broader ontology community to further refine this
information and integrate it within existing ontology development efforts.
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4.4 Data access and data mining
Users can access our database through a web interface at http://ardb.cbcb.umd.edu.
This interface provides several modes of interaction as highlighted below.
4.4.1 Keyword searches
Simple keyword search is available at the top of each page of ARDB website
(Figure 4.2a), providing a quick means for searching a specific object in our database
(gene, type, antibiotic, genome and genus) (Figure 4.2b to 4.2f). Users can search
all of the data, or narrow down the search to a specific type of information. For
example, users interested in the molecular mechanisms of resistance to tetracycline
can search for the keyword ‘tetracycline’ within the ‘Resistance Type’ database. An
advanced search function is also available, allowing users to select from among the
available keywords associated with each database field.
4.4.2 Similarity searches
4.4.2.1 BLAST
To help identify and annotate antibiotic resistance genes, a BLAST interface
is also provided. One or more sequences can be provided to this interface in a multi-
FASTA file, corresponding to a set of gene sequences. Furthermore, both nucleotide
and amino-acid sequences are accepted by our system. The results can be visual-
ized as standard BLAST output, however additional displays are provided that are
62
























Figure 4.2: Sample web pages from ARDB. (a) Front page, (b) resistance type, (c)
blast result, (d) mutation annotation, (e) browse and (f) genome information.
specific to antibiotic resistance information. Our ‘ARDB annotation format’ groups
individual BLAST hits according to resistance type as inferred from the level of sim-
ilarity to the genes within the database associated with a specific type of resistance
(Figure 4.2c). A second view allows users to download a tab-delimited spreadsheet
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summary of the antibiotic resistance genes identified within the uploaded file.
4.4.2.2 RPS-BLAST
In addition to BLAST we also provide an RPSBLAST interface relying on
Position Specific Scoring Matrix (PSSM) created from sequences associated with
each resistance type, using an approach similar to the NCBI Conserved Domain
Database. The output of this interface is similar to that provided by the BLAST
interface mentioned above.
4.4.2.3 Polymorphism detection
Additionally, a mutation-specific search function is provided to identify poly-
morphisms previously characterized to confer resistance (Figure 4.2d). For example,
a G-C mutation at position 1058 of the Escherichia coli 16S rRNA has been shown
to confer resistance to tetracycline [108]. This information is extracted from the
detailed BLAST alignment between the query sequence and a reference sequence
in our database. Currently this function is available for 12 genes (16S rRNA, 23S
rRNA, gyrA, gyrB, parC, parE, rpoB, katG, pncA, embB, folP, dfr), and we expect
to extend it as more information becomes available in the literature.
4.4.3 Pre-annotated information
The antibiotic resistance profiles of 632 complete bacterial genomes have al-
ready been annotated and deposited in ARDB allowing quick search. This informa-
64
tion can be conveniently extracted through keyword searches against the genome
database, or through the Genome Resistance Profiles Comparison link from the front
page. The latter approach allows users to summarize and compare the resistance
profiles of multiple organisms present in our database.
4.4.4 Browse
A ‘browse’ function is available that allows the users to visualize several classes
of antibiotic resistance genes, grouped by their resistance profile. This functional-
ity is currently available for aminoglycoside, β-lactam, macrolidelincosamidestrep-
togramin B, multidrug transporter, tetracycline and vancomycin resistance (Figure
4.2e).
4.4.5 Submission
In order to facilitate community-driven refinement of our database we provide
an interface through which users can submit information about novel resistance
genes. This interface captures several types of information not commonly available
in other databases [Minimum Inhibitory Concentration (MIC), resistance type, on-
tology, citation information, etc.]. Furthermore we provide a simple file format and
upload functionality to facilitate the submission of information for multiple genes.
The information received will be vetted and inserted into the database. We are also
planning to develop an interface that allows community-deposited information to
be directly added to the database as provisional records, pending additional manual
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curation.
4.4.6 Example: mining resistance genes with ARDB
Recent studies, through a functional metagenomic screening approach, have
shown that many environmental microflora are potential antibiotic resistance reser-
voirs even without much exposure to antibiotics (e.g., human microbiome [121] and
soil [3, 24]). We annotated four oral metagenomic samples including two controls
and two periodontal diseases (Figure 4.3), and found that the most common resis-
tance factors are for tetracycline, including genes previously encountered in the oral
microbiome tetM, tetW, tetO, tetQ, and tetS [115], as well as gene tet37 that con-
fers tetracycline resistance through unknown mechanisms and was originally cloned
from oral samples [27]. It is important to note that antibiotic resistance genes are
universally found in both cases and controls and cannot be exclusively linked to
periodontal disease, although the relatively abundances could be different.
4.5 Conclusion
The database described in this article, ARDB, unifies most of the publicly
available antibiotic resistance genes and provides a reliable annotation service to
researchers investigating the molecular basis for resistance in bacteria. Because of
the large diversity and the rapid identification of new resistance genes, the current
version of ARDB is just a first catalog of currently available information, and will























Figure 4.3: The abundances of antibiotic resistance genes identified in four oral
microbiome samples, including two controls (CT1 and CT2) and two periodontal
diseases (CP1 and CP2). The heatmap is colored according to the log2 of the num-
ber of reads (per 10 million metagenomics reads) mapped to each resistance gene
at 95% similarity cutoffs. ‘*’ or ‘#’ indicates that a particular resistance gene is
significantly enriched (p ≤ 0.05, Fishers exact test) in case or control samples, re-
spectively. MLS represents macrolide, lincosamide and streptogramin B antibiotics.
It is important to note that antibiotic resistance genes are universally found in both
cases and controls and cannot be exclusively linked to periodontal disease, although
the relatively abundances could be different.
our development efforts with researchers actively involved in antibiotic resistance
research as well as with the developers of biological ontologies and of databases
storing related information (such as virulence factors or toxins). As part of these
efforts we aim to refine the structure of our database, better determine the types
of information stored and identify additional requirements for the user interface.
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Future efforts will also target the development of new approaches for cataloguing
and characterizing polymorphisms correlated with resistance, as well as for anno-




Deep sequencing of the oral microbiome reveals signatures of
periodontal disease
This project is accomplished through extensive collaborations with several
external research groups, including Salomon Amar, Daniel Segre, Simon Kasif from
Boston University and Colin Stine from University of Maryland, School of Medicine.
The methods used in this study and results generated from this study have been
published in [82]. My specific contributions to this project are mainly data analyses
about taxonomic diversity and composition Figure 5.1 and Figure 5.3, statistical
comparison of metabolic networks Figure 5.2, genome assembly (Table 5.2, Table
5.3 and Figure 5.4) and genomic variation analysis Figure 5.5. I was also extensively
involved in the writing of the paper.
5.1 Background
Understanding the role of microbial communities in human health is emerging
as one of the most important and fascinating biomedical challenges of our times
[76, 128]. Our body harbors an enormous amount of microbial cells, estimated to
exceed the number of human cells by an order of magnitude. These microbes are
organized into complex communities specifically adapted to inhabit different niches
of the human body, such as the skin, and the respiratory, gastrointestinal, and
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urogenital tracts. Such ecosystems carry a broad range of functions indispensable
for the wellbeing of the host. At the same time, the rise of pathogens within such
communities, causing infection and inflammation, constitutes an ongoing challenge
in biomedical research. This is especially true in light of the slow rate at which
new antibiotics are discovered, and the increase in the number of microbes that
can resist treatment. In contrast to the traditional view of individual pathogens
being responsible for disease onset, recent microbial ecosystem diversity analyses
seem to point to a new perspective in which the transition from health to disease is
attributed to a shift in the global balance of the microbial flora rather than to the
specific appearance of individual pathogens. However, the mechanisms that underlie
the connection between disease or infection and the dynamics of the host-associated
ecosystems are still poorly understood.
In this work, we focus on the role of the oral microbial ecosystem in peri-
odontal disease. Periodontal disease is the most common infectious disease affecting
tooth-supporting structures. Left untreated, periodontitis can lead to, or aggravate
existing systemic conditions such as cardiovascular disease, diabetes, pulmonary dis-
eases, and obesity. In dentistry, understanding the changes in the oral microbiome
that foretell the early stages of periodontitis and dental caries, the most preva-
lent chronic oral diseases, may allow the better diagnosis and treatment before the
appearance of the telltale clinical manifestations of these diseases (such as tissue
damage in periodontal pockets or dental hard tissue loss). The emergence and evo-
lution of antibiotic resistance in periodontal pathogens has affected the therapeutic
success rates for this disease. New approaches are urgently needed to help regain
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control over periodontal disease, and microbiome studies offer a promising new angle
of attack. Unraveling the complex interactions that define the oral microbiome is a
fundamental, but complex component of this endeavor.
Recent developments in systems biology make it possible to perform quanti-
tative modeling of genome-scale metabolic networks for individual microbial species
[31] and have been recently extended to explore small microbial consortia, possibly
paving the way for future quantitative studies of the microbiome. However, at the
ecosystem level, current modeling efforts and quantitative analyses are heavily lim-
ited by the unavailability of relevant data. Towards this goal, increasingly accessible
metagenomic sequencing approaches hold the promise to enable a global systemic
view of the human oral microbiome. Recent advances in sequencing technology are
enabling scientists to generate billions of nucleotide bases at a fraction of the cost
per base of traditional methods. This deep sequencing has revealed an unexpectedly
high diversity of the human oral microbiome: dental plaque pooled from 98 healthy
adults comprised about 10,000 microbial phylotypes [62] - an order of magnitude
higher than the previously reported 700 oral microbial phylotypes as identified by
cultivation or traditional cloning and sequencing. The total diversity of the global
oral microbiome can be estimated to be around 25,000 phylotypes. To date, how-
ever, we do not know how many of these microbes contribute to periodontal disease,
what metabolic functions are key players in the transition from health to disease, or
how common or exclusive are the oral microbiomes of unrelated healthy individuals.
Here we combine the collection of whole-community sequencing data with a
number of computational analyses to provide a snapshot of the microbial compo-
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nent of periodontal disease at a high resolution. Specifically, we collected subgingival
plaque samples from healthy and periodontally affected patients and subjected them
to 16S rRNA analysis and deep sequencing in order to explore their microbiome.
Our analyses reveal a number of trends in genomic diversity and biological func-
tion enrichment during disease that allow us to formulate a novel hypothesis on the
nature of periodontal disease. We also demonstrate the power of high-throughput
sequencing approaches by reconstructing an unculturable member of the TM7 group,
complementing an initial analysis that relied on single cell genomic approaches. We
also characterize several regions of variation within one of the dominant members
of the oral cavity, Actinomyces naeslundii. This paper describes a genomic and
metabolic examination of the differences between the healthy and diseased peri-
odontal microbiome.
Note that this project is accomplished through extensive collaborations with
several external research groups, including Salomon Amar, Daniel Segre, Simon
Kasif from Boston University and Colin Stine from University of Maryland, School
of Medicine. My specific contributions to this project are mainly data analyses
about taxonomic diversity and composition Figure 5.1 and Figure 5.3, statistical
comparison of metabolic networks Figure 5.2, genome assembly (Table 5.2, Table
5.3 and Figure 5.4) and genomic variation analysis Figure 5.5.
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5.2 Results and Discussion
5.2.1 A deep look at the oral microbiome in health and disease
Current knowledge of the composition and functional spectrum of the human
oral microbiome is limited by the difficulty to culture the majority of microbes that
populate the oral cavity. We used deep sequencing technology to overcome this
limitation, and produce a substantial genomic dataset for the human microbiome
under health and periodontal disease conditions. Specifically, we generated both
16S rRNA and whole metagenomic data from five subjects (3 periodontally healthy
[H] and 2 chronic peridontitis [P] patients, see Table 5.1). A total of 495,195 16S
rRNA sequences were generated with the 454 FLX sequencing technology, yielding
an average of 30,000 sequences per sample after removing low-quality sequences
(roughly 3-times more sequences per sample than generated in a recent survey of
oral microbes [10]). A total of 272,709,876 sequence reads were generated using
the Illumina GAII platform, 76bp, paired-end run (mean library size 207bp) from
the whole metagenome of four of the above-mentioned subjects (2 H and 2 P). The
low quality nucleotides were trimmed from all sequences and fragments matching to
the human genome reference (NCBI release GRCh37.p1) were removed from further
analysis. The level of human DNA contamination varied between different samples
averaging about 87% of the sample, i.e. the oral microbiome represents just one
eighth of the entire dataset or a total of 33,681,771 (12.4%) sequences (Table 1).
This level of contamination is consistent with that observed in other studies, such
as the Human Microbiome Project (see hmpdacc.org and upcoming manuscript).
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Despite the moderate yield (in terms of fraction of microbial sequences in the data-
set) our results show that valuable biological insights can be derived from the data,
thus indicating that informative and clinically relevant whole-metagenomic analyses




# Reads Sample # Reads Sample
Disease
1(14) advanced 51,056 P11
9,725,937 P1 68.861(19) moderate 20,149 P12
1(30) moderate 41,355 P13
2(30) moderate 46,444 P21 4,893,057 P2 81.98
Healthy
3(1) healthy 23,702 H11
12,357,917 H1 60.613(2) healthy 44,869 H12
3(3) healthy 32,405 H13
3(4) healthy 56,116 H14
4(3) healthy 6,205 H21
6,704,860 H2 89.784(14) healthy 35,356 H22
4(19) healthy 14,110 H23
4(30) healthy 25,662 H24
5(3) early 12,295 H31
NA NA NA5(19) healthy 30,891 H32
5(30) healthy 12,605 H33
Table 5.1: Summary of sample information including high-quality read counts, tax-
onomic assignment of most abundant genus in each sample, and level of human
contamination. The clinical labels represent: ‘healthy’ - healthy periodontal pocket;
‘early’ - early periodontal disease (bleeding under probing but no attachment loss),
‘moderate’ - moderate periodontal disease; ‘advanced’ - advanced periodontal dis-
ease.
5.2.2 Beyond the taxonomical view of periodontitis
The standard view of periodontitis, largely based on traditional microbiologi-
cal approaches, associates the disease with the rise and damaging action of a small
set of well-characterized pathogens. A first question we wanted to address using our
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data is whether, and to what extent, this traditional view still holds from the vantage
point of metagenomic sequencing. Taxonomic profiling of the samples, whether de-
rived from targeted 16S rRNA sequencing or from whole-metagenomic data (WGS)
(see Methods and Figure 5.1) reveals a community dominated, on average, by the
bacterial phyla Firmicutes, Actinobacteria, Bacteroidetes, Fusobacteria and Pro-
teobacteria, consistent with previous studies [1,10]. Together, these groups account
for 80-95% of the entire oral microbiome. At the genus level we identify a total of 55
distinct genera in the 16S rRNA data and 58 distinct genera in the WGS data that
are present at an abundance of 0.1% or higher (an additional 73 and 62 rare genera
can be found in the 16S rRNA and WGS data, respectively). The most abundant
genera comprise previously characterized oral bacteria: Actinomyces, Prevotella,
Streptococcus, Fusobacterium, Leptotrichia, Corynebacterium, Veillonella, Rothia,
Capnocytophaga, Selenomonas, Treponema, and TM7 genera 1 and 5.
The TM7 division was prevalent in our samples (11 out of 15 samples contain
this division at > 2% abundance), averaging 5.7% (standard deviation 7.2) of the en-
tire population in the 16S rRNA data (WGS-based estimates also range about 6%),
and up to 26.8% in sample P11. This division was statistically enriched in diseased
samples (p ≤ 0.05, Metastats [133], Figure 1). TM7 is a novel candidate bacterial di-
vision with no cultivated representatives, and previous studies have shown microbes
from this division to be commonly found in the human oral flora but at relatively
low abundance, generally around 1% of the population [12,98], though abundances




Figure 5.1: Relative abundance of genera in the samples. ˆ - genus significantly
enriched in cases; # - genus significantly enriched in controls (p ≤ 0.05, Metastats
[133]). Only genera with >1% abundance in at least one sample included. Colors
reflect relative abundance from low (red) to high (white). Sample H31 (control)
clusters together with the diseased samples, confirming clinical observations of early
symptoms of periodontal disease (Table 5.1).
present in our samples, and their correlation with periodontal disease, indicate that
the prevalence of this poorly studied bacterial division within the oral cavity, and
its role in disease, have yet to be fully appreciated.
When comparing healthy and diseased samples we observe a shift in the com-
position of the oral microbiota (see Figure 5.1), supporting the well characterized
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transition (pvalue < 10−15 using Fisher’s exact test) from a gram-positive domi-
nated community in the healthy samples, to a gram-negative dominated community
in periodontal disease. On one hand, our findings recapitulate prior results that
indicate that the gram-negative genera Selenomonas, Prevotella, Treponema, Tan-
nerella, Haemophilus and Catonella are significantly enriched in periodontal disease.
Further, we have found a set of gram-positive genera that are significantly enriched
in healthy samples: Streptococcus, Actinomyces, and Granulicatella. Surprisingly,
however, neither Fusobacterium, nor Porphyromonas were found to be significantly
more abundant in the periodontal disease samples, despite being previously impli-
cated in this disease. This is likely due to the high variance in the abundance of
these organisms across our samples, as well as the small sample size which affects
our statistical power.
Clustering analysis 5.1 reveals sample H31 (a control) to have a microbiota
most similar to the diseased samples. This observation prompted a careful analysis
of the clinical data collected during sampling. The data revealed some symptoms
of mild periodontal disease (such as bleeding at probing time, see Materials and
Methods for more details) that were not found in any of the other healthy sam-
ples, indicating that the microbiota may shift into a disease state before the full
clinical symptoms of the disease are apparent. Also note that the diseased samples
(including H31) cluster together tightly while the healthy samples are more widely
distributed. This phenomenon is discussed in more detail below.
Taxonomic enrichment, however, cannot fully explain the etiology of periodon-
tal disease. All organisms that exhibit an enrichment in either healthy or diseased
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samples are present in all the samples, irrespective of disease status, i.e. the mere
presence of pathogens in the periodontal pocket is not sufficient to trigger periodon-
titis. The disease might be correlated with the presence of specific virulence factors
within the genomes of particular pathogens, or might be initiated once the abun-
dance of one or more pathogens crosses a specific threshold. The mechanisms that
keep pathogenic bacteria in check during health but allow them to bloom during
disease are not yet understood. These observations support our suggestion that a
full understanding of periodontal disease requires whole-genome and whole-system
analyses.
5.2.3 Metabolism, virulence factors and drug and metal resistance as
disease signatures
In addition to providing a taxonomic overview, our metagenomic sequencing
data contain high-resolution functional information. We annotated the function of
genes identified in the assembled whole-metagenome data according to the KEGG
Orthology, and used the resulting data to compare the functional potential of the
oral microbiome in health and disease. The metabolic profiles of healthy and dis-
eased samples differ in a number of important ways (Figure 5.2). The diseased
microbiome is enriched in metabolic functions that are consistent with a parasitic
lifestyle made possible by the availability of nutrients derived from the degrada-
tion of host tissue and from bacterial cells destroyed by the host immune response.
Among these are functions for fatty acid metabolism and acetyl-coenzyme A degra-
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dation, aromatic amino acid degradation, ferrodoxin oxidation, and energy-coupling
factor (ECF) class transporters. The periodontal pocket has been previously shown
to be enriched for such nutrients in patients with periodontitis [18]. Several of
these metabolic functions have also been associated with an intracellular lifestyle
(e.g. fatty acid metabolism [32], or with anaerobic metabolism (e.g., ferrodoxin ox-
idation, and acetyl-CoA degradation), highlighting the diversity of survival strate-
gies employed by the microbes inhabiting the periodontal pocket during disease.
Also enriched in disease are a number of virulence factors such as the presence of
conjugative transposons, type IV secretion systems, and the biosynthesis of toxic
factors (e.g., acetone, butanol, and ethanol biosynthesis), as well as the Lipid-A of
lipopolysaccharide (LPS) biosynthesis. LPS is a group of molecules known to trigger
host immune response and inflammation and their enrichment in disease provides a
possible explanation for the systemic impact of periodontitis on the human host.
Finally, the periodontal disease samples are enriched in a number of functions
related to drug and metal resistance (mercury, cobalt-zinc-cadmium). Mercury re-
sistance has been previously characterized as a common feature of oral bacteria,
even in the absence of mercury-containing amalgam, and is frequently associated
with antibiotic resistance [97]. The role drug resistance plays in disease is, however,
unclear as antibiotic resistance factors are present in both healthy and diseased
samples.
Comparatively, only a few pathways are significantly enriched in the healthy




















Figure 5.2: Metabolic pathways that are significantly enriched (found by MetaPath
[84]) in healthy samples (dark blue; p < 0.05), and that are significantly enriched in
diseased samples (dark yellow; p < 0.05). Figure is constructed with iPath [75].
acid biosynthesis, purine metabolism, and glycerol-3-phosphate metabolism. Cer-
tain fatty acids have been shown to have a protective role in periodontal health [63]
and it is possible that some of these are synthesized by the healthy microbiota.
However, most of what is known about the role of fatty acids in periodontal health
is based on nutritional studies and the contribution of the oral microbiota has yet
to be characterized. Glycerol-3-phosphate is a lipid metabolite that has been shown
to occur in higher concentration in periodontal disease samples [7]. Our study hints
that a possible explanation for this observation is a decrease in the ability of the
disease microbiome to metabolize this compound. Also enriched are genes related
to homoserine metabolism, possibly related to quorum sensing functions within the
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healthy microbiome, as homoserine lactones are frequently used as quorum sens-
ing molecules in oral bacteria. The enrichment, within our healthy samples, of the
reactions downstream of homo-serine lactone pathway may indicate a fully func-
tioning quorum sensing system, allowing for the communication between organisms
that is the hallmark of a healthy biofilm system. In poly-microbial biofilms it has
been shown that mutants lacking quorum sensing molecules, while able to construct
biofilms, are unable to obtain the correct structure and thickness. The depletion of
pathways related to quorum sensing in our diseased samples may indicate a possi-
ble cause of disease progression due to the inability of the healthy microbiome to
maintain a protective biofilm.
5.2.4 A systems level perspective on oral disease
The functional characterization reported above suggests that, beyond the tax-
onomic details, one can identify ecosystem-level signatures of periodontal disease
consistent with its clinical manifestations. However, from the above analysis, it is
still not clear whether these signatures reflect isolated instances of disease-related
molecular processes, or fit into a coherent picture of the disease as a predictably
different state of the whole oral microbial flora. We addressed this question by
performing additional analyses at different levels of resolution, and found that a
major systemic change seems to be identifiable between the healthy and diseased
microbiomes. The diseased samples harbor a more diverse microbial community (as
measured by the Shannon diversity index, Figure 5.3A), yet clustering analysis at
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the taxonomic level (Figure 5.1 and Figure 5.3B) and in terms of enzyme content
(Figure 5.3C), as well as pairwise comparisons of individual healthy and diseased
samples based on tetramer (subsequences of length 4) frequencies (Figure 5.3D),
all indicate that disease samples are more similar to each other than the healthy
samples. In other words, the diseased state appears to be associated with a con-
strained and predictable region in the space of all possible states a microbiome can
take. Thus, although the periodontal disease microbiomes are more diverse in terms
of community structure, that structure is quite similar across different patients.
In contrast, the healthy microbiome in any individual patient has relatively lower
taxonomic diversity, but its exact composition differs significantly across patients.
5.2.5 De novo assembly of oral microbes
The analyses we presented above have focused either exclusively on organisms
(16S rRNA diversity) or biological function (metabolic analysis), thus ignoring the
important link between organisms and the functions they perform. This connection
can only be made by reconstructing partial or entire organisms from the community
through metagenomic assembly. Currently, no practical genome assemblers exist
that are specifically designed for large-scale metagenomic assembly, thus we relied
on a hybrid assembly approach that combined de novo assembly using SOAPdenovo
(assembler used in a recent metagenomic analysis of gut microbes [101]), and align-
ments against a collection of oral microbes (see Methods). The results shown in































































































Figure 5.3: Systems-level analysis reveals the disease state to be an attractor in the
space of possible states for the microbiome. A - Shannon diversity is significantly
higher in diseased samples (community is more diverse). B - Disease samples cluster
together in PCA analysis of the taxonomic composition of the samples. Sample H31
(tooth with incipient periodontal disease from an otherwise healthy patient) appears
in the top right corner, clustering together with the disease samples; C - Disease
samples cluster together in the PCA analysis of the enzyme content of the samples;
D - Comparison of tetramer relative frequencies indicates disease samples are more
similar to each other than controls. Results in panel C and D are generated from
Daniel Segre group.
of 4.4 and 2.1 times larger (in terms of N50 contig size) assemblies than de novo
assembly and comparative assembly, respectively. Despite the relatively low level
of coverage in our data, we obtain fairly contiguous assemblies (average N50 contig
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size of 3.5Kbp), and are able to assemble up to about 50% of the total number of
reads in our data-set. Furthermore, consistent with our previous observation that
the periodontal disease samples are more diverse, the corresponding assemblies are
also more fragmented (average N50 contig size is 1.2Kbp in diseased samples ver-
sus 5.8Kbp in healthy samples). In addition, a pooled assembly of all four samples
results in dramatically increased contig sizes (max contig size is 16.9Kbp in pooled
assembly versus 7.6Kbp in individual assemblies), indicating these samples contain
closely related organisms.




SOAPdenovo 22,226 11.8 12 583 368 1.2 12.45
Comparative 26,464 16.7 16 1113 598 1.3 13.21
Hybrid 37,213 24.6 16 1829 1025 2.3 23.42
P2
SOAPdenovo 12,966 6.3 3.3 352 0 6.7 14.23
Comparative 13,841 8.5 35.2 490 0 5.7 11.69
Hybrid 21,835 12.5 37.6 647 396 10.5 21.39
H1
SOAPdenovo 45,658 3.1 22.6 3042 1648 5 40.2
Comparative 46,036 3.3 18.6 2437 1559 3.5 28.21
Hybrid 63,688 5.1 19 7567 3953 6.7 53.18
H2
SOAPdenovo 18,048 10.6 12.7 616 352 1.7 25.51
Comparative 16,107 13.6 26.8 1543 689 2.2 32.33
Hybrid 20,339 17.6 110 3934 1099 3.1 45.88
Pool
SOAPdenovo 98,051 54.9 15.7 2035 1342 8.1 24.12
Comparative 63,506 60.1 44.6 8415 5474 8.4 24.89
Hybrid 115,718 93.4 229.8 16896 9245 13.4 39.87
Table 5.2: Assembly statistics of metagenomic shotgun reads for contigs that are ¿=
300bp using (1) SOAPdenovo, (2) comparative assembly and (3) a hybrid approach
that uses MINIMUS to combine the contigs from the previous two methods. ‘Pool’
represents the assembly of all four samples together. N50 or N90 is defined as the
contig length such that equal or longer contigs produce 50% or 90% of 10Mbp.
84
5.2.6 Assembly of a TM7 genome
As described above, we detected a higher presence of TM7 organisms in our
samples than previously reported in literature. TM7 is a novel candidate bacterial
phylum without cultivated species, and previous studies have shown its high preva-
lence in human oral flora but with very low abundances [12,98]. The first sequence
of a TM7 organism (TM7a) was generated through single-cell isolation in a microflu-
idic device, followed by whole genome amplification [85]. Due to the artifacts of the
whole genome amplification approach, the resulting assembly is fairly fragmented
(see row 1 in Table 3). Here we relied on a hybrid assembly approach to recon-
struct a more complete version of this genome, using the corresponding shotgun
sequences generated in our project. Briefly, we started with the pooled assembly
of all our samples and extracted all contigs that are mapped to the previously se-
quenced TM7a genome, and scaffolded these contigs using Bambus 2 [65]. Finally,
we merged our TM7 assembly with the previously published assembly, derived from
single-cell sequencing, in order to construct the most complete (to date) assembly
of an organism from the TM7 group. The final assembly is still highly fragmented,
comprising over 1,500 contigs (Table 3), however it contains almost 50% more se-
quence than the single-cell derived assembly (2.3Mbp versus 1.7Mbp), and the N50
contig size is two times larger (790 bp versus 389 bp). These results highlight the
power of combining single-cell and metagenomic approaches when reconstructing
the genomes of unculturable organisms from metagenomic samples (5.4).
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Assembly # contigs Length(bp) Max(bp)
3Mbp
N25(bp) N50(bp)
HOMD TM7a reference genome 1,780 1,691,166 17,479 1,898 389
Hybrid assembly 1,340 1,478,421 13,917 1,753 NA
Scaffolds 874 1,593,887 20,925 5,093 482
Combine reference 2,222 2,209,727 17,514 2,904 790
Scaffolds 1,593 2,310,536 33,748 7,178 1,751
Table 5.3: Assembly statistics (calculated on contigs ≥ 300bp) for HOMD TM7a
reference sequences (row 1), hybrid assembly from metagenomic shotgun reads (row
2), Bambus scaffolding of hybrid assembly (row 3), assembly from combining hybrid
assembly and the HOMD reference sequences (row 4), and Bambus scaffolding of
































Figure 5.4: Distribution of contig sizes from TM7 reference genomes and the assem-
bly from our metagenomic sample. The upper plot shows the distribution of contig
size from TM7 reference genome, which is assembled from single-cell sequencing.
The lower plot shows the distribution of contig size from the assembly that com-
bines the contigs from TM7 reference genome and metagenome. Contig sizes that
are >= 5000bp are plotted as 5000bp.
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In addition, this improved TM7 genome assembly allows us to identify 703
genes that were not present in the original assembly (see Methods for details). In
order to evaluate the additional information contained in these genes, we annotated
them using the COMBREX [56] system (Supplementary Table 4). The analysis
revealed several potential virulence genes including an EmrB/QacA family drug re-
sistance transporter gene (Gene ID: 681 1) and two phage proteins (Gene IDs: 386 2
and 1828 4). These genes are not necessarily omissions from the original assembly,
rather they could represent de novo insertions into the TM7 genome present in our
sample. The set of novel TM7 genes does, however, included several housekeeping
genes (e.g., 10 ribosomal protein genes not present in the original assembly) which
should be conserved across TM7 genomes, thereby indicating that our assembly
improves upon our current understanding of the structure of the TM7 genome in
addition to revealing strain-specific genomic variants.
5.2.7 Genomic variation in Actinomyces naeslundii
Close analysis of one of the most abundant organisms in our samples (present
at 24- and 6-fold coverage in samples H2 and H1, respectively), a relative of Acti-
nomyces naeslundii MG1 (sequence ID SEQF1063 in the HOMD database), pro-
vides evidence for structural variations distinguishing this strain from the reference
strain originally isolated from a patient with mild gingivitis. The average similarity
between the assembled metagenomic contigs from our project and the reference se-
quence is 96.2% and 95.2% for samples CT1 and CT2, respectively (second and sixth
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ring in Figure 5.5). A number of genomic deletions with respect to the reference
strain are apparent in our samples, several of which contain potential virulence fac-
tors. These differences could be explained by the fact that the reference genome was
isolated from a patient with gingivitis, while in our samples the Actinomyces strains
are predominantly associated with healthy samples. Most striking is a deletion at
2120 kbp containing a putative mobile element encoding a mercury resistance locus
(including a mercury resistance gene, a site-specific recombinase, and an integrase).
Mercury resistance is commonly found in oral bacteria, frequently associated with
antibiotic resistance [97]. Interestingly, gene set enrichment analysis of the entire
metagenomic data-set reveals an enrichment of mercury resistance genes in the dis-
eased samples, possibly due to the association of these genes with virulence loci.
Several other deletions also appear to encode virulence factors - a drug transporter
(at position 580kbp in the reference strain) and an alcohol dehydrogenase gene
(at position 165 kbp) further underscoring the difference between the pathogenic
reference strain and the presumably commensal Actinomyces strains found in our
samples. Another two deletions (at positions 20kbp, and 1010kbp) contain genes
predicted to encode proteins involved in secretion and response regulation. These
deletions occur at slightly different locations in the two samples we analyzed, sug-
gesting they may be subject to rapid evolution.
Further evidence of the adaptation of Actinomyces to the oral environment is
revealed by the analysis of single nucleotide polymorphism (SNP) densities. In Fig-
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Depth of coverage
Figure 5.5: Systems-level analysis reveals the disease state to be an attractor in the
space of possible states for the microbiome. A - Shannon diversity is significantly
higher in diseased samples (community is more diverse). B - Disease samples cluster
together in PCA analysis of the taxonomic composition of the samples. Sample H31
(tooth with incipient periodontal disease from an otherwise healthy patient) appears
in the top right corner, clustering together with the disease samples; C - Disease
samples cluster together in the PCA analysis of the enzyme content of the samples;
D - Comparison of tetramer relative frequencies indicates disease samples are more
similar to each other than controls. Results in panel C and D are generated from
Daniel Segre group.
expected SNP densities (> 2 standard deviations from the mean). The most poly-
morphic regions correspond to genes known to be involved in the adaptation of an
organism to its environment: transcriptional regulators, known to evolve rapidly
in bacteria, and ABC transporters. Another highly-polymorphic region occurs
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within the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) gene, a virulence-
associated protein originally identified in Streptococci, which plays an important
role in the colonization of periodontal pockets by interacting with plaque-forming
bacteria. GAPDH was also shown to mediate the interactions between Streptococci
and Porphyromonas gingivalis fimbriae, possibly contributing to the colonization
of the subgingival pocket by P. gingivalis. These observations are consistent with
previous findings of high-SNP densities within genomic regions surrounding recom-
bination events.
5.3 Conclusion
Our study represents a important step towards characterizing the genomic
composition of the microbial communities associated with periodontal disease. We
have demonstrated that the subgingival microbiome can be effectively interrogated
through high-throughput sequencing, and that the resulting data provide valuable
insights into the molecular underpinnings of periodontal disease.
Despite a relatively small amount of bacterial sequence data recovered from our
samples (primarily due to the high level of human DNA contamination), a combina-
tion of comparative and de novo assembly approaches was able to reconstruct large
genomic segments from several dominant organisms in our samples, thereby allow-
ing a better reconstruction of an unculturable TM7 organism (in conjunction with
data generated through single cell genomic approaches), and providing a glimpse
at the genomic variation (and possible association with virulence) within Actino-
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myces genomes. Better assemblies were possible in samples that were sequenced
more deeply (e.g., sample H1), indicating the need to sequence the oral environ-
ment more deeply than has been done in this study. Furthermore, assembly quality
roughly correlated with disease status, partly confirming our observation (based on
16S rRNA data) that diseased samples had a higher microbial diversity. This obser-
vation also highlights a limitation of existing assembly tools in dealing with genomic
diversity, further underscoring the need for the development of metagenomic-specific
genome assemblers.
The analysis of the TM7 and Actinomyces genomes revealed signatures consis-
tent with recombination events possibly associated with virulence factors. Lateral
transfer of virulence determinants through phages and recombination is well docu-
mented in the bacterial world, leading to a partial separation between function and
phylogeny, thus, suggesting the need for metagenomic and functional analyses as a
complement to taxonomic surveys of host-associated microbiota.
Taxonomic analyses of the data we generated are consistent with a well es-
tablished community shift from a gram-positive dominated healthy microbiome to a
gram-negative dominated diseased microbiome, which is also enriched in a number
of oral pathogens. The molecular mechanisms that underlie and cause this transition
are, however, unknown. Here we have shown that functional information derived
from whole-metagenomic data provides a valuable complement to the taxonomic
data and allows us to develop a novel theory of periodontal disease. The healthy
state is highly regulated by the host immune system and interactions between com-
munity members to maintain a community dominated by few good microbes, usually
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gram-positive Actinobacteria or Streptococci. The transition to periodontal disease
involves a disruption of the host-microbiome interactions that results in a more even
community structure composed by a broad range of organisms that can thrive in the
oral environment. The presence of pathogens within this community can lead to the
clinical manifestations of periodontal disease, which in turn can lead to additional
changes in the community due to the increased availability of nutrients released
by the damaged tissue. As a result, the periodontal disease microbiome eventually
settles into a state characterized by a diverse population of microbes adapted to a
parasitic lifestyle made possible by the disrupted host homeostasis. One of the sam-
ples from our study was characterized by a microbiota typical of a diseased state,
yet the corresponding tooth was just starting to show some of the clinical symptoms
of disease. This observation implies that dysbiosis precedes the clinical manifesta-
tion of disease, and that the oral microbiota could be a potential tool for the early
diagnosis of periodontitis.
The large variability we observe between healthy samples, and even between
different teeth of a same person, highlights the limitation of using data derived from
cross-sectional studies to define what the core normal microbiome means. Further-
more, case-control studies are likely insufficient to determine the causal agents of
periodontal disease the organisms found to dominate the diseased microbiome (the
usual suspects commonly described in the literature) may simply be a symptom
of the disrupted subgingival environment rather than the primary cause of disease.
The usual suspects approach considers presence and absence of specific bacteria to
be the critical precondition for disease, however, our data support a more nuanced
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approach that considers quantitative and genomic differences as the critical factors
when moving from health to a diseased state. Longitudinal studies are necessary
to characterize the dynamic changes that occur in the oral microbiome in response
to environmental changes (food intake, changes in the host, etc.) and to track the
transition between the healthy and diseased states, and the return to health after
treatment.
It is important to note that the analyses described above are a preliminary
pilot project with limited sample size, and our observations must be confirmed in
more extensive studies. Furthermore, we focus on whether the microbiome has the
potential to perform certain biological functions, and on determining the relative
fraction of the microbial population that can perform a particular function. These
results (as well as those of similar metagenomic projects) must be complemented by
experimental studies aimed at determining whether the biological processes statis-
tically enriched in disease are actually active in the subgingival pocket.
As others have previously reported, and as observed in the data we have shown
here, periodontal disease is the result of a disruption of the complex interactions
occurring within the subgingival microbiome and between the microbiome and the
host. A full understanding of the etiology of periodontal disease will only be possible
through further in-depth systems-level analyses of the host-microbiome interaction.
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5.4 Materials and Methods
5.4.1 Subject population
The subject population consisted of 5 patients who were in good general health
and were recruited between August and November 2009 at the Clinical Research
Center, Boston University Goldman School of Dental Medicine. Written informed
consent was obtained from all enrolled individuals. The study protocol was reviewed
and approved by the Institutional Review Board at the Boston University Medical
Center. All subjects had at least 12 natural teeth with >20 years of age (age range,
28-45 years). Subjects diagnosed with chronic periodontitis (n=2) were selected
among those who had at least six sites with probing depth 6 mm and attachment
loss 5 mm. Subjects in the control (periodontally healthy) group had no pockets > 3
mm and no attachment loss > 2 mm at any site with no signs of periodontal inflam-
mation characterized by bleeding on probing, redness, edema, and attachment loss,
with the exception of subject 5 where one of the teeth (# 3, sample H31) exhibited
mild bleeding at probing time consistent with initial periodontal disease. Sites with
gingivitis were characterized by bleeding on probing, redness, edema, but no attach-
ment loss (pocket depth 4 mm). Sites from chronic periodontitis subjects further
characterized as mild, moderate or advanced periodontitis sites based on the pocket
depth. Mild periodontitis was characterized with pockets > 4 mm but not more
than 5 mm; moderate periodontitis was characterized with pockets > 5 but < 7
mm while advanced periodontitis was characterized with pockets > 7 mm. Healthy
group consisted of subjects of Asian, Caucasian and African American origin, while
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periodontitis subjects were of Caucasian and African-American origin. Exclusion
criteria included pregnancy, lactation, systemic conditions that could affect the pro-
gression or treatment of periodontal diseases. In addition, none of the subjects had
received systemic antibiotics or periodontal therapy in the previous 6 months.
5.4.2 Data collection, sequencing and preprocessing
16S rRNA sequences were processed and filtered based on quality with an in-
house pipeline as follows. First, sequences containing at least one unrecognizable
base-pair (‘N’), and that were too short (< 75 cycles of the 454 instrument) were
excluded from further analysis. Then, barcode sequences were deconvoluted and
removed.
Metagenomic sequencing was performed on pooled DNA from multiple teeth in
order to obtain sufficient DNA concentrations for library construction. Metagenomic
shotgun sequences were obtained from the Illumina instruments in fastq format and
were trimmed for quality using the FastX Toolkit (Hannon Lab, CSHL) with the
following parameters: (1) minimum length 25, and (2) q-value cutoff 20. Sequences
containing at least one ambiguity character (‘N’) were also removed. The remaining
sequences that passed the quality trimming outlined above were mapped to the
human genome reference (NCBI build 37 v 1) downloaded from NCBI using Bowtie
with parameters (-v 3; at most 3 mismatches) If one of the sequences from a paired
end matched the human genome, then both sequences were removed from the data-
set. The remaining reads were mapped against the human sequences in the NCBI
95
nr database using BLAST in order to remove human sequences not present in the
NCBI human genome reference. For this additional check we required at least 95%
global identity (since BLAST is a local alignment algorithm, our calculation also
takes into account the length of the unaligned segments flanking the hit reported
by BLAST).
5.4.3 Clustering and annotation of 16S rRNA sequences
The entire set of trimmed 16S rRNA sequences were clustered into Operational
Taxonomic Units (OTUs) with the program DNACLUST [42], using a 1% radius (-r
2). To obtain the taxonomic identities, the OTU centers were aligned using BLAST
to the RDP database [19] augmented with oral clones from the HOMD database [16],
and were annotated using the lowest common ancestor approach (similar to the
approach in [55]). The assignment process is conservative: (1) only sequence with
at least global 98% identity with the reference is classified; (2) if there are more
than one equally good best hits, then the sequence is classified using the lowest
common ancestor approach; (3) otherwise it is classified as unknown. Finally, the
taxonomic label of the OTU center is transferred to the sequences from the same
OTU cluster. The resulting data was organized in a collection of tables at different
taxonomic levels containing each taxonomic group as a row and each sample as a
column. These tables formed the substrate for the further statistical analyses.
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5.4.4 Assembly
We mapped and assembled the samples against reference sequences for oral mi-
crobes extracted from the Human Oral Microbiome Database (HOMD, http://www.homd.org)
as follows:
1. We used MUMmer [70] (-maxmatch -l 20 -b) to map the individual reads
against the HOMD reference database.
2. Reads that mapped with higher than 80% global identity were then assembled
based on the mapped coordinates of the reads.
3. This process was repeated using a 90% similarity threshold, but mapping
the reads against the assemblies generated at step 2, rather than against the
HOMD database.
4. The resulting contigs were then combined with the results of a de novo assem-
bly of the data, as described in more detail below.
We used SOAPdenovo V. 1.04 with parameters -K 23 and -M 3, as previously
used by the MetaHit project to assemble gut microbiome data. Contig sequences
longer than 100bp, which were generated by our customized comparative assembly
pipeline and by SOAPdenovo, were combined and assembled using MINIMUS with
the following parameters: (1) minimum overlap length 40bp, and (2) overlap error
rate is 0.1.
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5.4.5 Estimation of SNP rates and genetic diversity
After assembly, the shotgun reads were mapped back to the contigs using
Bowtie [73] allowing at most 3 mismatches. To avoid sequencing and mapping
errors we used a conservative approach as suggested in [68]: we only retained SNPs
occurring in regions with a depth of coverage higher than 4, and with each individual
haplotype represented in at least two different reads. The SNP rate was calculated
using a 5Kbp window and a 100bp step size.
We adapted the approach used in [47,59] to infer the genetic diversity θ from
metagenomic shotgun sequencing data using composite likelihood estimators while
accounting for a constant sequencing error rate. First we classified the nucleotide
positions of the assembled contigs into k groups, where k is the maximum depth
of coverage of the contigs, and positions within the same group have the same
depth of coverage. The number of nucleotide positions in each group is denoted by
n1, n2, ..., nk. Considering the large number of bacteria in the sampled community
relative to the number of reads sequenced, the probability that each read derives
from a different individual microorganism is close to one. Thus, we have a popula-
tion size equal to the depth of coverage at every site in the assembled contigs [59].
Consequently, the estimator can be obtained by calculating the expected number of
true SNPs and false SNPs due to sequencing errors [47]. Then for a particular nu-
cleotide group with the same depth d, assuming an infinite sites model, the expected




= Sd − Serrord (5.1)
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where Sd is the observed number of segregating sites (SNPs) from data and S
error
d
is the expected number of segregating sites induced by sequencing errors. For a nu-
cleotide position with depth of coverage d, the probability of at least two mutations










ex(1− e)d−x = 1− (1− e)d − ne(1− e)d−1 = ed (5.2)
Since there are nd such sites with depth of d, the expected number of segregating
sites induced by error is Serrord = nded. Hence the estimated θ̂ for regions with d

























In our calculation, we assume a constant sequencing error rate e = 0.01. The θ value
is calculated using a 1Kbp window moving average (which is roughly the average
gene size in bacteria) with 100bp step size. Regions of the genome that had a value of




MetaCompass: Comparative Assembly of Metagenomic Sequences
The methods, algorithms and experiments in this study originated from dis-
cussions between Dr. Mihai Pop and me. I developed the program and performed
the experiments. Dr. Mihai Pop and I write the manuscript together. At the time
of writing this dissertation, the paper is under preparation.
6.1 Introduction
Microorganisms comprise the majority of Earth’s ecological diversity, and they
play important functional roles in virtually all ecosystems. Particularly, human-
associated microbial communities play a critical role in health and disease [53]. In
many environments, however, more than 99% of the bacteria cannot be cultured by
standard laboratory techniques [126]. Metagenomics is a new scientific field that
involves the analysis of organismal DNA sequences obtained directly from an envi-
ronmental sample, enabling studies of microorganisms that are not easily cultured
in a laboratory. Metagenomic studies, pioneered in the early 2000s, have recently
increased in number and scope due to the rapid advances of high-throughput se-
quencing technologies, e.g., GS FLX system from 454 Life Sciences and Genome
Analyzer from Illumina company, which permit large amounts of DNA to be se-
quenced quickly and cheaply. For example the MetaHit consortium has generated
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about 500G raw sequences from 124 human gut samples in its initial analysis [101],
the Human Microbiome Project has produced more than 7 trillion base pair DNA
reads [20], and the newly initiated Earth Microbiome Project is planning to se-
quence 200,000 samples with 6 billion base pairs per sample, totaling 1200 trillion
bp DNA (http://www.earthmicrobiome.org/). There is a pressing need to extract
meaningful biological information from the deluge of metagenomic sequences.
So far, one of the biggest challenges in analyzing next-generation sequences is
the short read length. Although many sophisticated computational tools have been
specifically developed for the short reads, e.g., MetaGene [92] for gene prediction,
PhyloPythia [86] and PhymmBL [11] for taxonomic classification, the performance
is still not very satisfactory in many applications. For example, the accuracy of
PhymmBL (one of the most accurate classifier for genomic fragments) for 100bp
reads is about 60% at the genus level. All these limitations, however, can be alle-
viated through metagenomic assembly. Genome assembly is the process of piecing
together short DNA fragments, which are randomly extracted from a sample, to form
a set of longer contiguous stretches of DNA strings called contigs, which form the
foundation for many important downstream analyses, e.g., gene prediction, genomic
variation discovery, etc.
In traditional single-genome projects, the most difficult part of genome as-
sembly is handling repetitive regions (DNA repeats), which are the major cause
of misassembly. The assembly of metagenomes, however, brings about additional
assembly challenges in the form of non-uniform read depth due to non-uniform dis-
tribution of species abundance, multi-strain population (quasispecies) in the natural
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environment, and the potential for the coassembly of reads originating from different
species (chimeric contigs). Hence, the performance of de novo assemblers is signifi-
cantly compromised when assembling complex metagenomic samples. Despite these
challenges, various de novo assemblers, based on either overlap-layout-consensus
approach or De Bruijn graph, have been developed and applied to the assembly of
metagenomes from massive amounts of short reads. For example, on average only
about 40% of the reads in human gut metagenomic sample can be assembled into
contigs that are longer than 500bp using SOAPdenovo [101]. The performance of
these de novo assemblers [74, 79, 119, 139] is far from satisfactory when assembling
metagenomic sequences. Mainly because most of the whole-metagenome shotgun
projects are sequenced by Illumina technology producing a huge amount of short
DNA reads, which are usually computational unmanageable using the traditional
overlap-layout-consensus approach. Instead, they are assembled using De Bruijn
graph based approach. The performance of De Bruijn graph assemblers relies on
counting the abundance of k-mers. However, in metagenomic sample, usually the
genome of one species is represented by millions of small variants of a consensus
genome. Hence, this will potentially create many low-abundance k-mers and might
significantly reduce the power of De Bruijn graph.
Instead of building another de novo assembler to compete with existing ones,
we try to improve metagenomic assembly from another perspective: constructing a
robust comparative assembler for metagenomics, which further can be used to com-
plement de novo assemblies of the same data. Comparative assembly simply works
as follows: at the beginning the short DNA reads are aligned to a reference genome
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of a closely related species, then contigs are built from the reads following the guid-
ance of the reference genome. Previously, The AMOS comparative assembler [100]
has been developed specifically for reference assisted assembly, but is generally only
applicable for the analysis of individual genomes when the references are known, and
not directly suitable for comparative assembly in metagenomics, for which usually
no prior information about the reference genomes are available and at least dozens of
reference genomes are needed per sample. Other previously developed tools usually
only use comparative assembly to improve de novo assembly in very limited setting
instead of building a full-fledged comparative assembler, e.g., bridge gaps [29, 127]
and orient contigs into bigger scaffolds [54].
So far, thousands of bacterial genomes have been sequenced, and the number
is expected to grow rapidly in the next few years, e.g., accordingly to the Genomes
Online database (http://www.genomesonline.org) 1416 bacterial genomes have
been completed and 6114 are ongoing. These sequenced genomes provide a great
resource for performing comparative assembly of metagenomic sequences, because
with the guidance of a reference genome, it is relatively easier to construct con-
tigs spanning hypervariable regions and repeats within a composite population of
genomes.
In this paper we develop algorithms and a software tool to improve metage-
nomic assembly through comparative genomics and hybrid combination. We show
that comparative assembly can achieve comparable results to the state-of-the-art de
novo assembler in terms of assembly statistics. Additionally, we show that compar-
ative and de novo assemblies are complementary to each other, and the combination
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of these two can significantly improve the final metagenomic assemblies.
6.2 Methods and Materials
6.2.1 Methods overview
Figure 6.1 shows an overview of the MetaCompass comparative assembly
pipeline. First we use MetaPhyler [80] to estimate the genomic compositions for
all available reference genomes that might present in a metagenomic sample. Then
the genomes with high depth of coverage are used as reference genomes for further
comparative assembly. Afterwards, the metagenomic shotgun reads are mapped to
the reference genomes using MUMmer-map developed in this study, or any other
alignment tool that produces results in SAM format (e.g., Bowtie 2 [72] and BWA
( [77])). Subsequently, based on the read alignments we build contigs using a min-
imum set cover algorithm, and use an iterative mapping approach to improve the
contigs. Finally, the contigs are combined with assembly from de novo approaches to
produce final results. Each step will be described in detail in the following sections.
6.2.2 Selecting reference genomes
In contrast to comparative assembly for single genome, a big challenge for
metagenomics is the fact that we do not know what reference genomes we should
use from thousands of genomes available in public databases. One simple solution
is to use all available genomes as reference genomes, but this approach has sev-




























Figure 6.1: Overview of MetaCompass comparative assembly pipeline. First, we
estimate the abundances of all available genomes in the sample using MetaPhyler.
Next, genomes with high depth of coverage are extracted and used as reference
genomes for assembly. Afterwards, metagenomic shotgun reads are aligned against
these genomes using MUMmer-map, Bowtie 2 or BWA. Subsequently, we build con-
sensus contigs using the minimum set cover algorithm and use an iterative mapping
approach to improve the consensus contigs. Finally, the contigs are combined with
assembly from de novo approaches to produce final results.
is computationally expensive and challenging, e.g., the index size limit for both
Bowtie [73] and BWA [77] is about 4Gbp, substantially smaller than the total size
of reference genomes available today. In addition, using all the available genomes
requires a significant amount of memory during mapping, which may limit the us-
ability of the tool in practice. Essentially, we only need to use reference genomes
whose close relatives are present in the sample at high enough coverage to allow
assembly (i.e., we only care about abundant reference genomes). To identify these
genomes, we first run MetaPhyler to estimate the taxonomic composition, and then
only genomes with high enough depth of coverage are used as references for further
comparative assembly. MetaPhyler relies on phylogenetic marker genes as a taxo-
nomic reference to quickly and accurately estimate the taxonomic composition. The
depths of coverage of the reference genomes are estimated based upon the reads that
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are successfully classified.
6.2.3 Aligning reads to reference sequences
Comparative assembly starts with aligning shotgun reads to reference genomes,
and typically this step is very computationally expensive because a massive amount
of alignments need to be performed. Read mapping is a very fundamental problem
in many computational biology problems, and plenty of read mappers [72,73,77] are
available, especially for re-sequencing analysis of large eukaryotic genomes. Many
of them are very fast for aligning reads that have very few mutations (e.g., less than
4 substitution errors). But the performance drops quickly when there are many
mutations, especially insertions and deletions (e.g., bwa-short is mainly designed
for sequencing error rates below 2%), which are quite common in metagenomic
settings, because (i) bacterial species mutate and evolve fast, (ii) metagenomes
usually contain a population of similar genomes for a particular species, (iii) the
reference genomes diverge from the environmental sequences because of the vast
diversity of unknown bacteria in the environment. In order to achieve high sensitivity
for metagenomic read mapping, we should allow more differences than commonly
encountered in the analysis of eukaryotic genomes.
In this project, as an alternative to Bowtie 2 [72], we developed a metagenomic
read mapping tool (named as MUMmer-map) based on finding maximal exact seeds
[70] and Smith-Waterman alignment extension (Figure 6.2). We first build a suffix
tree [70] for the reference genomes. Then to align the reads, between each query read
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and genomes, a set of maximal exact matches that are longer than a threshold (18bp
by default) are identified and are used as alignment seeds for next step. Afterwards,
the left and right surrounding sequences between the query and reference are aligned










Figure 6.2: Mapping reads to reference genomes. First, exact alignment seeds (max-
imal exact matches defined in MUMmer) are found by aligning shotgun reads to the
suffix tree of reference genomes. Then surrounding sequences of the seeds are aligned
between the query and reference through Smith-Waterman algorithm.
Since this paper is not about short read alignment, performance comparisons
with other read mappers are beyond the scope of this paper. Our whole compara-
tive assembly software is designed and developed in a modular way such that any
read mapping tools can be used without interrupting the whole assembly process.
Specifically, MetaCompass supports the SAM alignment format [78] produced from
many popular tools, e.g., Bowtie and BWA.
6.2.4 Building contigs
As described above, at the beginning, we use MetaPhyler to choose a set of
candidate reference genomes. This process may retrieve too many genomes as we
may have multiple reference genomes that are very similar to each other from the
same species. When building contigs, if a metagenomic read is mapped to more than
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one reference genomes equally well, we need to decide which reference genome(s) to
use.
Figure 6.3a shows that if we use all the read mapping records disregarding
whether the read is uniquely mapped or it is mapped to multiple reference genomes
equally well, then potentially we will create many redundant contigs because of the
similar genomic regions. Figure 6.3b shows that if we randomly pick one of the
multiply-mapped alignments, then we may create many fragmented small contigs,
which ideally should form one continuous big contig. Figure 6.3c shows that we
can assign a read to the genome with highest depth of coverage, because the more
abundant this genome is in the sample, the more likely that this read comes from
it. This approach produces much better results than that from 6.3a and 6.3b. A
fourth solution we propose is to pick a minimum set of genomes such that all of the
reads can be mapped to at least one of them (Figure 6.3d).
Once we have identified this set of genomes, they will be ranked by the number
of reads that can be mapped to each of them. The assemblies are built using the
reference genomes one by one according to the rank. Note that once a read is used
in a reference genome with higher rank, it will be discarded and not available for
genomes with lower rank. The basic idea here is to use as few reference genomes as
possible (being parsimonious), but at the same time trying to assemble more reads,
construct longer contigs and avoid redundancies.
Formally, this problem can be framed as a set-cover problem, which is NP-hard
and is an optimization problem that models many resource-selection problems [22].
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(a) Read mapping (b) Randomly pick best reference
(d) Minimum set cover(c) Rank by depth of coverage
(a) Read mapping - all records (b) Pick reference randomly 
(d) Minimum set cover(c) Rank by depth of coverage
Figure 6.3: Building contigs from read mapping records. Shorter bars represent
shotgun reads; longer and thicker bars represent reference genomes (4 genomes in
this figure). Regions with the same color in the reference genomes represent highly
similar sequences. (a) All read mapping records. A read may be mapped to several
reference genomes equally well, e.g., 5 yellow reads are mapped to both of the first
two genomes. (b) For each read, if it is mapped to more than one reference genomes,
we randomly pick one record. (c) A read is assigned to a reference with highest depth
of coverage. (d) We pick the minimum number of reference genomes, to which all
reads can be mapped.
An instance (X,F) of the set-covering problem consists of a finite set X (the shotgun
reads that can be mapped to reference genomes) and a family F (reference genomes)
of subsets of X, such that every element of X (each shotgun read) belongs to at





where each subset S is a set of reads mapped to a particular reference genome. The
problem is to find a minimum-sized subset C ⊆ F (minimum number of reference






Here “a reference genome covers a read” means that this read can be mapped to this
reference genome. To solve this problem, we use a greedy approximation algorithm
(see below) by picking, at each stage, the set S (genome) that covers the greatest
number of remaining elements that are uncovered. The algorithm works as follows.
The set U contains, at each stage, the set of remaining uncovered elements (reads).
The set C contains the cover being constructed (reference genomes that are picked).
Line 4 is the greedy decision-making step. We choose a subset S that covers as many
uncovered elements as possible with ties broken randomly. After S is selected,
its elements are removed from U , and S is placed into C . When the algorithm
terminates, the set C contains a subfamily of F that covers X. It can be shown that
this greedy algorithm is the best-possible polynomial time approximation algorithm
for the set cover problem, under plausible complexity assumptions.
Algorithm 2 Greedy approximation for minimum set covering problem.
Input: a finite set X; a family F of subsets of X.
Output: a subset C ⊆ F whose members cover all of X.
1: U ← X
2: C ← ∅
3: while U 6= ∅ do
4: select an S ∈ F that maximizes |S ∩ U |
5: U ← U − S
6: C ← C ∪ S
7: end while
8: return C
Given a set of reference genomes, a set of shotgun reads and the alignment
between each read and reference genome, the process of creating contigs is straight-
forward. For each nucleotide base of each reference genome, we look at the bases
from the reads that are mapped to this locus, and pick the nucleotide with the
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highest depth of coverage as the consensus (Figure 6.4). In addition, to introduce
an insertion, its depth of coverage should be higher than half of that of its neighbor
nucleotides (Figure 6.4). Minimum depth of coverage and length for creating contigs































Figure 6.4: Creating consensus contig sequences from reads that are mapped to
reference genomes using the majority rule.
6.2.5 Improving assembly through iteration
In metagenomic studies, it is common for a genome in the sample to not have
very close relatives in the currently available reference genomes, or to have a hyper-
variable region that can not be aligned to the reference very well. To assemble such
genomes, previous studies [29,127] have shown that iterative assembly is a promising
approach which can increase both the contig size and the number of assembled reads.
Iterative assembly simply works as follows (Figure 6.5): (i) map shotgun reads to the
original reference genomes; (ii) create contigs based on the reads that are aligned;
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(iii) use the newly created contigs and their surrounding sequences from the original
genomes as new reference sequences, and iterate previous two steps multiple times




















































Figure 6.5: Iterative mapping can potentially improve comparative assembly. Here
in this toy example, we assume that a read is considered as mapped when it has
less than 3 mismatches. Hence the top read enclosed in red rectangle will not be
mapped to the reference at the beginning. If no iteration is performed, two short
contigs will be created from the comparative assembly. If iteration is performed, the
top read will be successfully mapped to the new reference, producing a single long
contig.
6.2.6 Combining comparative and de novo assemblies
As we have discussed before, comparative assembly is quite sensitive to genome
recombinations, insertions or deletions, which unfortunately occur in bacterial genomes
even between closely related species. Given that the bacterial genomes we have se-
quenced so far form only a very small subset of all bacterial species in our earth
ecosystem, using a comparative approach will lead to fragmented assemblies or may
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fail to reconstruct novel species. de novo assembly, on the other hand, does not
rely on any previous information, so it can, in principle, recover any genomes from
the sample. In contrast, de novo assembly can reconstruct novel genomes but is
affected by sequencing errors and repeats. Combining the two approaches allows us
to partly mitigate their respective weaknesses and benefit from their complemen-
tary strengths. By leveraging previous available tools in genome assembly, we use
a light-weight assembler MINIMUS [120] to directly combine the contigs generated
from the two approaches. MINIMUS has been used successfully in [48] to combine
contigs from Velvet and Edena. We should note that we do not handle assembly
errors very well during the combination at this point even if one assembly may be
able to correct the other one. The parameters we used are: (i) minimum overlap
length is 100bp; (ii) overlap similarity cutoff is 95%.
6.2.7 Materials
Even and staggered metagenomic samples of mock community from the Hu-
man Microbiome Project were downloaded from the NCBI Short Read Archive with
project ID 48475. The Illumina reads of 728 metagenomic samples from the Hu-
man Microbiome Project were downloaded from the Data analysis and Coordination
Center (http://www.hmpdacc.org).
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6.2.8 Parameters used in data analysis
In all results and analysis in this paper, only contigs longer than or equal
to 300bp are considered. Boxplots were created using default settings in R. All
software tools used in this study were run under default parameters, unless specified
otherwise.
6.3 Results and Discussions
In this section, we first evaluate MetaCompass on two artificial metagenomic
samples for which we know the genomic composition, and compare its performance
with four other assemblers: AMOScmp [100], Meta-IDBA [96], MetaVelvet [139] and
SOAPdenovo [79]. Then, we compare their performance using one real tongue dor-
sum metagenomic sample, which was generated by the Human Microbiome Project
(HMP) and has been used previously in Meta-IDBA [96] for evaluation. Finally,
to demonstrate the performance and applicability of MetaCompass on large-scale
metagenomic data sets, we analyzed 728 metagenomic samples from the HMP
project, and compared its performance with SOAPdenovo and a hybrid assembly
approach.
6.3.1 Assembly evaluation using two artificial metagenomic samples
We evaluated the performance of MetaCompass and four other assemblers on
two synthetic (also known as mock) microbial communities, which were created from
purified genomic DNA of 20 bacteria and eukaryotes for which finished genome se-
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quences are available (Table 6.1) [20]. The two artificial communities were created
such that the 16S rRNA copies of the organisms have a uniform distribution for the
even community and long-tail power law distribution for the staggered community.
After sequence quality trimming, 18.6 and 33.2 million Illumina reads with average
length 98bp and 95bp were obtained for even and staggered samples, respectively.
The taxonomic composition of the sequenced metagenomic reads from these two
samples was estimated using MetaPhyler [80] (Figure 6.6). The taxonomic com-
position of the mock even community is more uniform than that of the staggered
community (entropy values are 3.39 versus 1.66), but the abundance distribution
of the mock even community is still far from uniform, even after correcting for 16S
rRNA copy variations. This may reflect the experimental biases coming from the
sample preparation, sequencing technology, etc.
When testing the performance of MetaCompass on these two mock samples,
we created two scenarios. In the first we assume the genomic composition of the
mock communities is given (denoted as MC-Ref in figures) , and we run MetaCom-
pass directly using the 22 true reference genomes. The assembly results can be
considered as an upper bound on MetaCompass performance, because we know the
exact genomes for the metagenomic reads to be assembled. In the second scenario,
we run MetaCompass in normal settings (no prior information about genomic com-
position) on these two samples, and the reference genomes are selected according to
the depth of coverage estimated from MetaPhyler. To compare the performance, we





Acinetobacter baumannii ATCC 17978 1.60E-10 1.60E-11
Actinomyces odontolyticus ATCC 17982 7.82E-11 7.82E-13
Bacillus cereus ATCC 10987 3.73E-11 3.73E-11
Bacteroides vulgatus str. ATCC 8482 1.52E-10 1.52E-12
Candida albicans ATCC MY-2876 3.27E-11 2.92E-11
Clostridium beijerinckii ATCC 51743 3.81E-11 3.81E-11
Deinococcus radiodurans ATCC 20539 1.76E-09 1.76E-11
Enterococcus faecalis str. ATCC 47077 2.22E-11 2.22E-13
Escherichia coli ATCC 70096 2.71E-11 2.71E-10
Helicobacter pylori ATCC 700392 4.50E-11 4.50E-12
Listeria monocytogenes ATCC BAA-679 1.53E-11 1.53E-12
Lactobacillus gasseri str. ATCC 20243 3.98E-11 3.98E-12
Methanobrevibacter smithii ATCC 35061 9.50E-11 9.50E-10
Neisseria meningitidis ATCC BAA-335 6.87E-11 6.87E-12
Propionibacterium acnes DSM 16379 1.39E-10 1.39E-11
Pseudomonas aeruginosa ATCC 47085 1.80E-10 1.80E-10
Rhodobacter sphaeroides ATCC 17023 1.30E-10 6.97E-11
Staphylococcus aureus ATCC BAA-1718 6.97E-11 1.31E-09
Staphylococcus epidermidis str. ATCC 12228 1.31E-10 1.83E-11
Streptococcus agalactiae ATCC BAA-611 1.83E-11 4.70E-10
Streptococcus mutans ATCC 700610 4.70E-11 8.11E-13
Streptococcus pneumoniae ATCC BAA-334 8.11E-11 6.97E-11
Table 6.1: Genomic composition of even and staggered mock samples [20]. The
two artificial communities are created such that the 16S rRNA copies of the organ-
isms have a uniform distribution for the even community and long-tail power law
distribution for the staggered community.
assemblers: SOAPdenovo [79], MetaVelvet [90] and Meta-IDBA [96], and one com-
parative assembler AMOScmp [100]. When running AMOScmp, we assume that
the 22 reference genomes are known, because this software was designed for single
genome comparative assembly, and does not have the ability to automatically se-
lect the reference genome. The three de novo assemblers were run under default
parameters. In the following, we compare the assembly performance using three
measurements: contig size, assembly error, and coverage of reference genomes (see
Methods for details).
Figure 6.7 shows the comparison of contig sizes between different assemblies on
even and staggered mock data sets. The trajectory shows the contig length (y axis)
















































































































































































































































































Figure 6.6: Taxonomic compositions of even and staggered mock metagenomic sam-
ples estimated from metagenomic shotgun reads using MetaPhyler. Genome depth
of coverage (y axis) is estimated by MetaPhyler based on classified phylogenetic
marker genes.
than or equal to the contig length represented on the y axis. The y axis is represented
in log scale. As expected, MetaCompass with known true reference genomes creates
the longest contigs among all approaches (red curves in Figure 6.7). MetaCompass
without prior information about the genomic composition performs second best
(blue curves in Figure 6.7), and it performs better than AMOScmp (AMOS-Ref;
brown curves), even though AMOScmp uses the true reference genomes. Especially,
from Figure 6.7 we can tell that MetaCompass creates some very long contigs (almost
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completely covers the abundant genomes), and this will be very helpful for some
further genome-scale analysis. For the staggered metagenomic sample (Figure 6.7b),
MetaCompass is consistently better than AMOS-Ref. For the even metagenomic
sample in Figure 6.7a, MetaCompass is significantly better than AMOS-Ref when
cumulative size is smaller than 30Mbp, and drops below AMOS-Ref afterwards. The
reason is the reference genomes selection procedure wherein, reads are assigned to
genomes with a greedy approach according to the rank (see Methods for details).
Reads coming from similar genomic regions (e.g., 16S rDNA) in different genomes
will all be assigned to the genome of highest rank. Hence, this will produce fewer
contig sequences, and fragment the assemblies for lower-rank genomes into smaller
pieces.
Next, we compare the quality of the contigs generated from different assem-
blers by looking at the number of mis-assembled contigs. There are many different
measures of accuracy, and we take a simple approach that is similar to the Feature
Response Curve proposed by [91]: a contig is counted as one error if it can not be
aligned to the true reference genomes contiguously. Here we ignore the number of
break points required to align the error contig to reference. We first sort the con-
tigs in decreasing order by length, and plot the cumulative contigs length (y axis)
against the number of misassembled contigs (Figure 6.8). MetaCompass (MC-Ref
in Figure 6.8) makes very few errors when using true reference genomes; in contrast,
AMOScmp (AMOS-Ref in Figure 6.8) creates a lot more errors even given the true
genomes. MetaCompass (blue curve in Figure 6.8) without knowing true reference
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Figure 6.7: Accumulative contig size distribution of different assemblies for even and
staggered mock metagenomic samples. The contigs are sorted in order of decreasing
length. The contig length (y axis) is plotted against the accumulative size (x axis)
of the contigs whose lengths are smaller than or equal to y axis. The accumulative
contigs size (x axis) is plotted against the contig size (y axis). Note that the y axis
is in log scale, so a difference by one indicates a 10 times difference in real contig
length. MC-Ref and AMOS-Ref assume the true reference genomes are given when
running MetaCompass and AMOScmp assemblers.
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genomes is still better (makes fewer errors) than AMOScmp. Also from Figure 6.8,
we can tell that almost all errors made by MetaCompass come from small contigs;
whereas other assemblers make much more errors in large contigs. Since the errors
from MetaCompass are in small contigs, they will only affect the quality of further
genomic analysis very slightly. Among the three de novo assemblers, we see that
SOAPdenovo produces more contig sequences than the other two, but at the same
time, also produces much more errors.
The above two evaluation measurements can not recognize assembly that pro-
duces redundant contigs. To address this issue, for each assembly we map the contigs
back to the true reference genomes and calculate the regions that are covered (Fig-
ure 6.9). Again, MetaCompass with known reference genomes (MC-Ref in Figure
6.9) covers the largest amount of reference genomes. MetaCompass covers slightly
fewer reference genomes than MC-Ref does, and AMOS-Ref demonstrates similar
performance with MetaCompass. Among the de novo assemblers, SOAPdenovo as-
sembly covers much more reference genomes than the other two do, but as we have
observed before (Figure 6.8), it also creates much more errors.
Given that the genomes in the metagenomic sample have been sequenced be-
fore, reference based comparative assembly indeed can produce longer contigs than
de novo assemblers do. However, keep in mind that in real metagenomic samples,
closely related reference genomes are frequently not available, especially for samples
120













































































Figure 6.8: Distribution of assembly errors generated by MetaCompass and four
other assemblers on the two mock metagenomic data sets. The contigs are sorted
in decreasing length, and the cumulative contigs size (y axis) is plotted against the
number of erroneous contigs. MC-Ref and AMOS-Ref assume the true reference
genomes are given when running MetaCompass and AMOScmp assemblers.
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Figure 6.9: Number of bases of the reference genomes that are covered by assembled
contigs. MC-Ref and AMOS-Ref assume the true reference genomes are given when
running MetaCompass and AMOScmp assemblers.
from novel environments. So, in this section we are not suggesting that MetaCom-
pass should substitute de novo assemblers, rather that when good reference genomes
are available, MetaCompass can produce significantly longer and more accurate as-
semblies. Comparative assembly by MetaCompass should also be performed beside
de novo assemblies to achieve best overall metagenomic assembly.
6.3.2 A tongue dorsum metagenomic sample from HMP
We use a real human tongue dorsum metagenomic sample from the Human
Microbiome Project [20] to evaluate the performance of assemblers in practice. The
reason we choose this data set is because it had been used previously by Meta-
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IDBA [96]. Figure 6.10 shows the taxonomic composition at the genus and phylum







































































































Figure 6.10: Taxonomic composition of a tongue dorsum metagenomic sample esti-
mated by MetaPhyler. Only genera and phyla, whose abundances are higher than
1%, are shown in this figure.
Figure 6.11 shows the comparison of contig sizes from different assemblies. In
addition to the assemblers mentioned in the previous section, we also used MINIMUS
[120], a light-weight assembler, to combine the contigs between MetaCompass, and
MetaVelvet or SOAPdenovo. Individually, the performance of the assemblers do
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not differ significantly; MetaVelvet produces the largest assemblies; MetaCompass
appears to be better than others between 20Mbp and 50Mbp of cumulative size
(Figure 6.11). The combination of either MetaCompass and MetaVelvet (MC+MV
in Figure 6.11), or MetaCompass and SOAPdenovo (MC+SOAP in Figure 6.11)
produces significantly more in total size and longer contigs than any individual
assemblers.
Redundant contigs can artificially inflate the contig size statistic used above.
To prevent this situation, we calculate the number of reads that are assembled for
each assembly by mapping the reads back to the contigs using Bowtie 2 (Figure 6.12).
MetaVelvet assembles about 52.6 million reads (62.7%), which is more than any
other assembler does; the two combination approaches (MC+MV and MC+SOAP in
Figure 6.12) assembled 61.8 (73.5%) and 68.1 million reads (81.1%), which represent
huge improvements over individual assemblers alone. In summary, in this real tongue
dorsum metagenomic sample, the performance of MetaCompass is comparable to
the state of art de novo assemblers, and the hybrid approach gives the overall best
assembly.
6.3.3 728 metagenomic samples from HMP
We further evaluate the performance of MetaCompass on 35.7 billion Illumina
shortgun reads from 728 metagenomic samples of the Human Microbiome Project























































Figure 6.11: Accumulative contig size distribution of different assemblies for a
tongue dorsum metagenomic sample. The contigs are sorted in order of decreas-
ing length. The contig length (y axis) is plotted against the accumulative size (x
axis) of the contigs whose lengths are smaller than or equal to y axis. The accumu-
lative contigs size (x axis) is plotted against the contig size (y axis). Note that the
y axis is in log scale, so a difference by one indicates a 10 times difference in real
contig length. MC+MV represents combinations of contigs from MetaCompass and
MetaVelvet; MC+SOAP represents combinations of contigs from MetaCompass and
SOAPdenovo.
individuals. One major goal of HMP is to systematically characterize microbial
communities found at different human body sites, and to provide genomic references
for future human related metagenomic studies. Here we demonstrate the power
of MetaCompass by analyzing all these samples, and combine the assembly with
the contigs generated from SOAPdenovo (Figure 6.13). In total, MetaCompass
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MC+MV MC+SOAP MetaVelvet SOAPdenovo MetaCompass Meta−IDBA





















Figure 6.12: Number of reads assembled in different assemblies for a tongue dorsum
metagenomic sample from HMP. The statistic is calculated by mapping the reads
back to contigs.
assembled 33.3 billion base pairs (Gbp) in contigs that are longer than or equal to
300bp; SOAPdenovo produced 44.1Gbp contigs, which were assembled by the HMP
data analysis consortium previously (http://www.hmpdacc.org/). It is expected
to see that SOAPdenovo produced more contigs than MetaCompass does, because
the reference genomes we have for the human microbiome only account for a tiny
portion of the diverse population of bacteria species living with us. The contig
sizes of MetaCompass, however, are bigger than that of SOAPdenovo, because the
reference genomes can easily help us resolve repeats during comparative assembly
(Figure 6.13). For example, the average maximum contig size across all samples
from MetaCompass is 131Kbp compared with 86Kbp from SOAPdenovo.
Before we combine the contigs from MetaCompass and SOAPdenovo, we an-
alyzed the redundany of the contigs from these two approaches to see if we can




















































































































































































































Figure 6.13: Assembly statistics of comparative assembly (MetaCompass), de novo
assembly (SOAPdenovo) and a hybrid approach (MC+SOAP) for 728 HMP metage-
nomic samples. “# reads assembled” is calculated by mapping reads back to the
contigs using Bowtie 2. “Contig size of nMbp” is computed as the contig length
such that using equal and longer contigs produce nMbp.
answers to these two questions: (1) How many contigs from SOAPdenovo can be
mapped to reference genomes selected by MetaCompass? (2) Are the reads assem-
bled by MetaCompass a subset of the reads assembled by SOAPdenovo? To answer
the first question, we aligned all the contigs generated by SOAPdenovo to reference
genomes using BLAST (similarity cutoff: 90%; alignment length cutoff: 300bp),
and extracted the contigs that were successfully matched. Figure 6.14 shows that
only a very small portion can be aligned against the reference genomes, indicating
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that SOAPdenovo assembled many novel contigs relative to the reference genomes
used by MetaCompass. Specifically, out of the 44.1Gbp contigs generated from
SOAPdenovo assembly, only 17.8B can be mapped to reference genomes. To answer
the second question, we compared the reads that were assembled by SOAPdenovo
and MetaCompass by mapping reads back to the contigs. In total about 11.2 bil-
lion reads are assembled by both approaches; 9.3 and 7.6 billion reads are uniquely
assembled by SOApdenovo and MetaCompass respectively (Figure 6.15). These
















































































































































































































Figure 6.14: Assembly statistics of comparative assembly (MetaCompass), de novo
assembly (SOAP) and contigs produced from SOAP that can be mapped to reference
genomes (SOAP(ref)) on 728 HMP metagenomic samples.
To combine the contigs from MetaCompass and SOAPdenovo, we choose to use
a previously developed overlap-layout-consensus based fast and lightweight assem-

























Figure 6.15: Venn diagram showing the number of reads assembled by SOAPdenovo
and MetaCompass. In total, 28.1 billion (78.7%) out of 35.7 billion reads are assem-
bled into contigs longer than or equal to 300bp by SOAPdenovo and MetaCompass
combined. 11.2 billion reads (27%) are assembled by both approaches.
produces much better results than either MetaCompass or SOAPdenovo does indi-
vidually. In total, hybrid assembly produces 58.4Gbp contigs, whereas MetaCom-
pass and SOAPdenovo produces 33.3Gbp and 44.2Gbp contigs respectively. The
significant increase in the amount of contigs assembled is not a result of redundant
sequences, because the number of reads assembled also increases significantly to 28.2
billion reads (79% of all reads). Overall, the contigs assembled from this hybrid ap-
proach significantly improves the performance and increases our ability to analyze
complex metagenomic samples.
In addition, we analyzed the assembly results separately for seven body sites
(buccal, fonix, nares, retroauricular, stool, supragingival, and tongue), from which
more than 10 samples were sequenced (Figure 6.16). The relative performance of
MetaCompass and SOAPdenovo varies significantly across body sites. Regarding
buccal samples, MetaCompass is better than SOAPdenovo in all categories, e.g.,
MetaCompass assembled 2.97Gbp contigs from 777 million reads, while SOAPde-
novo generated 1.87Gbp in contigs from 551 million reads. For tongue samples,
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MetaCompass produced 7.3Gbp in contigs from 4.9 billion reads and SOAPdenovo
produced 11.7Gbp in contigs from 5.4 billion reads. However the average maximum
contig size of MetaCompass (130.1Kbp) is larger than SOAPdenovo (110.9Kbp).
The performance of de novo assembly depends heavily on how complex the com-
munity is and the amount of repetitive sequences in the genomes; in contrast, the
performance of comparative assembly depends on how close the reference genomes
are to the genomes in the metagenomic sample.
6.3.4 Improvements from iterative assembly
In metagenomics, we might frequently see mutation hotspot regions, where our
target genomes in the sample are not very similar with available reference genomes.
The shotgun reads coming from these regions can not be mapped to the reference
genomes because of the large differences, resulting in fragmented contigs. Fortu-
nately, iterative assembly potentially can help us approach the consensus genome in
the natural population, and walk through the hotspot genomic regions (see Meth-
ods for details). To verify the assembly improvements gained from iterative as-
sembly, here we show the results from 728 metagenomic samples from the Human
Microbiome Project. During the comparative assembly, we have performed three
iterations, and Figure 6.17 shows the corresponding assembly statistics. The total
number of reads assembled increases from 17.4 to 18.8 billion reads, and the aver-
age maximum contig size increases from 106Kbp to 131Kbp. Overall, the iterative


















































































































































































































































































































































































































Figure 6.16: Assembly of HMP samples by body site. Each row represents a distinct




























































































































































































































































Figure 6.17: Improving comparative assembly through iterative mapping for 728
metagenomic samples from the Human Microbiome Project. Both the contig size
and the number of assembled reads are improved significantly.
6.3.5 Discovering genomic variation
Comparative and de novo assemblies are two independent and complementary
ways to reconstruct genomes from metagenomic shotgun sequences. As shown above,
a hybrid approach improves the overall assembly significantly, and allows for better
further computational analysis, e.g., taxonomic annotation, gene prediction and
annotation, genomic variation, etc. In addition, since the contigs from comparative
assembly are automatically aligned against the reference genome, it gives us an
easy way to explore genomic variations. Here we show an anecdotal example of the
discovery of a potential genomic recombination event.
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Cmp1 and Cmp2 are two contigs assembled by the comparative approach
from sample SRS011126 of the Human Microbiome Project, and the gap between
them is about 1.3Kbp based on their coordinates relative to the reference genome
Treponema denticola ATCC 35405 (Figure 6.18(a)). The gap could be caused by
several reasons, e.g., deletion, recombination or low depth of sequencing coverage,
and we hope that the hybrid approach could help us bridge this gap. In the hybrid
assembly these two contigs are connected by a contig (named as Soap1) from the de
novo assembly (Figure 6.18(b)), and the gap between them is about 0.5Kbp based
on the coordinates relative to this new contig. This 0.5Kbp gap is much shorter
than the original 1.3Kbp gap, and also these two gap sequences are not similar to
each other (as determined by BLASTN alignment), indicating a potential genomic
recombination event. Then we analyzed the gene annotations from the GenBank
record (Figure 6.18(a) and Table 6.2) around these two contigs in the reference
genome, and have identified genes that might cause this genome recombination
event, e.g., XerD phage integrase family site-specific recombinase.
Gene name Start End Strand GenBank ID Annotation
BspA 2792010 2792750 + NP 973335 Cell surface antigen BspA.
PepF 2792903 2794633 + NP 973336 Oligoendopeptidase F.
EamA 2794813 2795229 + NP 973337 EamA-like transporter family.
RmsS 2795342 2795830 + NP 973338 Type I restriction-modification system.
TprL 2796003 2796782 + NP 973339 TPR repeat lipoprotein.
XerD 2796940 2797749 − NP 973340 Phage integrase: site-specific recombinase.
RmsS 2797810 2798337 + NP 973341 Type I restriction-modification system.
Table 6.2: Gene annotations around the contigs Cmp1 and Cmp2 based on reference
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Figure 6.18: Hybrid assembly of contigs from comparative (Cmp1 and Cmp2) and
de novo (Soap1) assemblies. Figure (a) shows the creation of contigs Cmp1 and
Cmp2 guided by the reference genome Treponema denticola ATCC 35405. Figure
(b) shows that Cmp1 and Cmp2 can be connected by contig Soap1 from de novo
assembly. Soap1 overlaps with Cmp1 by 134bp with 1 mismatch, and overlaps with
Cmp2 by 526bp with 1 mismatch.
6.3.6 Running time and memory usage
We compared the running time and peak memory usage of the assemblers
(Figure 6.19) using the even mock metagenomic data set. The peak memory usage
of MetaCompass is much smaller than that of other assemblers under comparison
(Figure 6.19b). The memory usage of MetaCompass is invariant to the number of
the metagenomic reads to be assembled, rather it linearly depends on the size of the
reference genomes (about 8 bytes per base pair). The running time is worse than the
three de novo assemblers (Figure 6.19a), but it grows linearly with the number of
metagenomic reads, and can be easily run in multiple threads or processes to achieve
linear speedup (parallel execution is available through command-line option). Also,
during the initial reference genome selection by MetaPhyler, instead of using all
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the reads, the users can sample a subset of the reads to estimate the taxonomic
composition. The reasons why MetaCompass is slower than MC-Ref (MetaCompass
with given true reference genomes) are: we need to run MetaPhyler at the beginning,
and MetaPhyler usually proposes a much larger reference genomes set than the truth.







































Figure 6.19: Comparison of running time and peak memory usage on the even mock
metagenomic sample. Running time is calculated as the CPU usage time in a single
thread. MC-Ref and AMOS-Ref assume the true reference genomes are given when
running MetaCompass and AMOScmp assemblers.
6.4 Conclusions
In this project, we have developed a new comparative genome assembler specif-
ically for metagenomic sequences. We show that MetaCompass can achieve com-
parable results to the state-of-the-art de novo assembler, and much better than
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AMOScmp, a single genome comparative assembler. Furthermore, we show that
MetaCompass and de novo assemblies are quite complementary to each other, and
the combination of these two approaches can significantly improve individual per-
formance. Overall, MetaCompass is highly applicable to the analysis of large-scale
metagenomic data sets, and also can run on typical personal computers with small
memory capacity. The algorithm, however, is not perfect, for example, although
the performance of reference genomes selection in MetaCompass is very good in the
mock metagenomic datasets, it is still significantly worse than when we know the
reference genomes exactly. So one future direction for research is improved refer-
ence genome selection, e.g., by analyzing the depth of coverage of different regions
across the genomes. This will avoid assigning the reads that come from a similar re-





During my PhD research, I have developed efficient algorithms and tools pri-
marily for large-scale metagenomic sequences analysis. The tools and algorithms
have been used by many people in the research community, and helped them un-
derstand the underlying biological systems from different perspectives, discover in-
teresting patterns or phenomena in their own data sets. We have demonstrated
the efficiency and capability of our tools by applying them to several real-world
biological data sets, including the largest available so far, the Human Microbiome
Project, which has generated near 10 terabytes of raw sequences. My research has
also resulted in interesting biological findings.
In addition, I want to summarize my research in terms of contributions from a
computational perspective (for details see Section 1.3). During the development of
the above-mentioned computational algorithms and tools, we have employed, cus-
tomized and improved previous algorithms significantly. MetaPath is a statistical
algorithm that can be adapted to compare any weighted networks. Previous meth-
ods usually, partitioned the network into a set of discrete features. Also we have
introduced another nonparametric p-value which takes into account the network
structure. ARDB database is specifically designed for the information retrieval and
analysis of a particular set of genes. The infrastructure, data integration and rep-
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resentation approach can be generalized to building databases for other biological
genes. Because a lot of biomedical information are stored as semi-structured data,
ARDB provides a framework for compiling and building specialized gene databases.
MetaPhyler is a hierarchical training and classification software for biological se-
quences. It automatically learns the similarity distributions within each group in-
duced by the given taxonomy. During classification, MetaPhyler computes a confi-
dence score for each classification at each hierarchical level, and hence it can easily
identify novel taxonomic group from the query. In addition to taxonomic classifi-
cation, MetaPhyler can also be adapted to functional annotation of biological se-
quences. Furthermore, the algorithm can also be applied to text classification when
a hierarchy is available (e.g., music has subtypes such as pop, country music; both
music and sports belong to entertainment). MetaCompass is the first algorithm and
tool that allows efficient comparative assembly of metagenomic sequences, and it
improves the overall metagenomic assembly performance by about 40%.
We will continue improve our algorithms and maintain our tools to accommo-
date the fast-growing sequencing technologies, and we hope our tools will continue
benefit the general research community.
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Appendix A
Comparative analysis of antibiotic resistance genes reveals insights
into the evolution of drug resistance in Staphyloccus aureus
A.1 Background
Staphylococcus aureus, a Gram-positive bacterium discovered in the 1880s,
is a leading cause of hospital-acquired infections affecting as many as 2% of newly
admitted patients [134]. S. aureus is the most frequent cause of surgical site in-
fections, lower respiratory tract infections, and cardiovascular infections and is the
second most frequent cause of healthcare - associated pneumonia and blood stream
infections [103]. According to recent estimates, >400,000 S. aureus related hospital-
izations occurred per year in the United States, causing 11,000 deaths annually [64].
In 1942 the first penicillin-resistant S. aureus isolate was observed in a hospital just
two years after the introduction of penicillin in medical use. In 1961, two years after
the introduction of methicillin, S. aureus developed resistance through the acquisi-
tion of mecA gene. During the last 45 years, various hospital-associated methicillin-
resistant S. aureus (HA-MRSA) clones spread worldwide. Since the 1990s, more vir-
ulent community-associated MRSA (CA-MRSA) clones have emerged and become
increasingly prevalent. The ability of S. aureus to develop resistance to virtually all
classes of antimicrobial agents increasingly complicates efforts to prevent and treat
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infections, especially in hospitalized patients. Morbidity and mortality caused by
drug resistant S. aureus strains have increased the financial burden on health care
systems and lead to strong interest in studying the evolution (in terms of acquisi-
tion and distribution of antibiotic resistance genes) of this organism, which is poorly
understood [93].
A.1.1 Antibiotic Resistance in Staphylococci
Methicillin resistance in staphylococci is conferred by the mecA gene encod-
ing a penicillin-binding protein PBP2’, which catalyses the cross-linking of cell wall
peptidoglycan and has a low affinity for beta-lactam antibiotics. Staphylococcal
cassette chromosome (SCC) elements are, so far, the only vectors described for the
mecA gene, and this large fragment of mobile DNA is designated SCCmec. SCCmec
elements can integrate into the genome of staphylococci at a unique site (attBSCC)
near the origin of replication [57]. According to their putative cassette chromo-
some recombinase genes (ccr) and overall genetic compositions, six different types
of SCCmec have been identified and characterized [94]. Staphylococcal genomes
seem to change continuously as genetic elements move in and out, but no mech-
anism has been found responsible for transferring SCC elements between different
staphylococcal species.
One of the key features of S. aureus has been its ability to readily acquire
resistance to antibiotics, often through lateral gene transfer. The adaptability and
resilience of S. aureus is highlighted by the large number of MRSA strains that
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plague our hospitals worldwide (HA-MRSA) and by new virulent MRSA clones that
have emerged recently as a major cause of severe community-acquired (CA-MRSA)
infections [33]. Differentiating between community and hospital-acquired strains
is difficult. Two putative characteristic features of CA-MRSA are the presence of
type IV SCCmec and PantonValentine leukocidin (PVL) gene. However, no studies
have proven the exact biological roles of these elements in the pathogenesis of CA-
MRSA. In fact, CA-MRSA strains exist that possess neither SCCmec IV nor the
PVL locus [38, 109]. Although antibiotic resistance genes are important genetic
factors in the pathogenesis of MRSA, no comprehensive analysis of these genes has
been performed.
The rapidly increasing volume of genomic sequence data generated from staphy-
lococci represents a tremendous resource for studies of bacterial diversity and evo-
lution. At the time of writing, 18 complete and 5 draft Staphylococcus genomes
are available from the NCBI genome database with many more sequencing projects
underway. In this study we compare the sequenced Staphylococcus genomes on the
basis of their antibiotic resistance profiles as predicted by a newly created database
of antibiotic resistance factors [81]. Our analysis reveals a strong correlation of
antibiotic resistance genes with the adaptation of S. aureus to community and hos-
pital environments. By tracking the horizontal gene transfer events of antibiotic
resistance genes and SCCmec elements in the sequenced Staphylococcus genomes,
and mapping them to the phylogenetic tree, we show that these transposable ele-
ments can be acquired by different Staphylococcus lineages independently, strongly
supporting the hypothesis that MRSA strains have emerged on multiple independent
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occasions. Finally, we conduct a survey of staphylococcal antibiotic resistance genes
and demonstrate that different staphylococcal strains share a common reservoir of
antibiotic resistance genes.
A.2 Results and Discussion
A.2.1 Correlation of Niche Adaptation (Ecological Fitness) with An-
tibiotic Resistance
Community acquired and hospital acquired MRSA have distinct phenotypic
characteristics, e.g. CA-MRSA strains are more virulent, grow faster and contain
fewer resistance genes. To better understand the genetic underpinnings of the differ-
ences between CA-MRSA and HA-MRSA, we compared 23 Staphylococcus genomes
(Table A.1) on the basis of their antibiotic resistance genes, annotated using the
ARDB database [81]. Although these different staphylococci have a relatively short
evolutionary history, especially within the S. aureus lineage, the number of resis-
tance genes varied dramatically. For example, S. aureus N315 carries 17 antibiotic
resistance genes, but only three antibiotic resistance genes are identified in S. aureus
MW2 (a CA-MRSA strain) and two are identified in S. aureus RF122 (a bovine iso-
late) (Figure A.1). Such large variation in antibiotic resistance gene content might
play a role in the ecological adaptation of individual strains and pathogenic poten-
tial, especially because these strains are frequently subject to antibiotic treatment.
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Organism Strain Source SCCmec Type MLST Type Clonal Complex
S. aureus COL Early Isolate I 250 8
S. aureus JH1 Hospital IIb 105 5
S. aureus JH9 Hospital IIb 105 5
S. aureus MRSA252 Hospital IIa 36 30
S. aureus MSSA476 Community NA 1 1
S. aureus Mu3 Hospital IIa 5 5
S. aureus Mu50 Hospital IIa 5 5
S. aureus MW2 Community IV 1 1
S. aureus N315 Hospital IIa 5 5
S. aureus NCTC8325 Lab Strain NA 8 8
S. aureus Newman Early Isolate NA 254 8
S. aureus RF122 Bovine NA 151 151
S. aureus USA300 Community IV 8 8
S. aureus USA300 TCH1516 Community IV 8 8
S. epidermidis RP62A Hospital IIb NA NA
S. haemolyticus JCSC1435 Hospital N1 NA NA
S. epidermidis ATCC 12228 Noninfectious Strain NA NA NA
S. saprophyticus ATCC 15305 Community NA NA NA
S. aureus CF-Marseille Hospital IVa NA NA
S. aureus JKD6008 Hospital IIa 239 8
S. aureus JKD6009 Hospital IIa 239 8
S. aureus Mu50-omega Hospital IIa 5 5
S. aureus TCH959 Community NA 8 8
Table A.1: 18 complete and 5 draft (the last five rows) Staphylococcus genomes.
Hospital acquired staphylococci carry more antibiotic resistance genes (mean:
11.5, standard deviation: 2.3) than their community acquired counterparts (mean:
5.8, standard deviation: 3.4) or other staphylococcal strains (mean: 3.4, standard
deviation: 1.2) (Figure A.1). This observation is unsurprising as HA strains need to
survive in the antibiotic-intensive hospital environment. One exception is S. aureus
TCH1516, a community acquired strain that acquired eight antibiotic resistance
genes within a plasmid. S. aureus TCH1516 has the potential to colonize a hospital
environment, consistent with its increasing prevalence. When comparing the num-
ber of antibiotic resistance genes only within the main chromosome, the separation
between CA- (mean: 3.5, standard deviation: 0.5) and HA-MRSA (mean: 10.3,
standard deviation: 2.4) strains becomes more significant. An explanation could be
that HA-MRSA strains lose the environmental fitness to compete with CA-MRSA in





Figure A.1: Comparison of the number of antibiotic resistance genes in staphy-
lococcal genomes isolated from different environments. The antibiotic resistance
genes for each staphylococcal genome are computationally predicted and summa-
rized. Based on the habitat source, staphylococcal strains are classified into three
groups: hospital-acquired, community-acquired and other (non-human pathogens,
lab strains, or uncertain origin). Dark grey bars represent antibiotic resistance genes
found in chromosomes and light bars represent antibiotic resistance genes found in
plasmids.
tance genes, which in turn are necessary to survive in a hospital setting due to high
drug pressure. Compared with its close relative S. aureus USA300 (another commu-
nity acquired strain), S. aureus TCH1516 has the same resistance genes within the
main chromosome. The fact that most of the resistance genes within the S. aureus
TCH1516 are on a plasmid, which is different from the plasmid found in S. aureus
USA300, may allow it to easily modulate their expression in order to avoid high
metabolic costs and therefore retaining fitness in an environmental setting.
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Frequently, HA-MRSA strains contain many duplicated (more than one copy
of a same resistance gene) or redundant (more than one gene conferring the same
resistance profile) resistance genes , possibly providing an explanation for the higher
abundance of resistance genes within HA strains. This dosage effect, however, does
not fully explain the difference between hospital and community-acquired staphylo-
cocci. HA strains appear to also have more diverse resistance profiles, in terms of
the spectrum of antibiotics they can tolerate. To assess this effect we compared the
genomes on the basis of their resistance profile alone, ignoring the actual number
of genes conferring a certain type of resistance. Specifically, each Staphylococcus
genome was represented as a 0/1 characteristic string where each character indicates
whether this strain is resistant (0 for sensitive; 1 for resistant) to a specific antibiotic
or a group of antibiotics. We then constructed a parsimony tree (Figure A.2; see
methods for details) from the resulting strings. In this antibiotic resistance profile
tree, HA-MRSA and CA-MRSA strains are located in two distinct clusters, high-
lighting their different resistance profiles. As an outgroup we chose a hypothetical
strain sensitive to all antibiotics (a character string with all zeroes). As seen in the
figure, the hospital-acquired strains have resistance to a broader spectrum of antibi-
otics than their community-acquired counterparts. All HA-MRSA strains have the
methicillin-resistant gene mecA, but only some CA-MRSA strains have this gene.
For example, S. aureus TCH959 and S. aureus MSSA476 are CA-MRSA strains that
lack the mecA gene. Most HA-MRSA strains are resistant to bleomycin (a glycopep-
tide antibiotic inhibiting DNA metabolism) conferred by the ble gene, while none
of the CA-MRSA strains are resistant to this antibiotic. All HA-MRSA strains are
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resistant to macrolide, lincosamide and streptogramin B (MLSB) antibiotics, but
only S. aureus USA300 and TCH1516 in CA-MRSA are resistant to MLSB, which
explains why these strains cluster close to the HA-MRSA cluster (Figure A.2). In
recent years, replacement of MRSA strains in some hospitals by CA-MRSA strains
with enhanced drug resistance has been observed [116]. The resistance phenotypes
of S. aureus USA300 and TCH1516 may indicate their potential to colonize hospital
environment.
A.2.2 Horizontal Gene Transfer of Antibiotic Resistance Genes and
SCCmec element
Two opposing theories have previously been suggested to describe the rela-
tionship between the first MRSA isolates and recent MRSA clones. The single-
clone theory suggests that all MRSA clones have a common ancestor, and that
SCCmec element was introduced only once into S. aureus [67]; the multi-clone the-
ory hypothesizes that SCCmec was introduced several times into different S. aureus
genetic lineages [35,93]. Distinguishing between these two theories requires an accu-
rate reconstruction of the evolutionary history of S. aureus strains, which is difficult
due to the short evolutionary time since the emergence of MRSA strains. Meth-
ods based on genome rearrangement and inversion [50] and multi locus sequence
typing [34] have been proposed. However, S. aureus genomes do not contain suf-
ficient genome rearrangement events [38]. Further, MLST sequences frequently do







Figure A.2: Maximum parsimony tree of antibiotic resistance profiles for 23 staphy-
lococcal genomes. The antibiotic resistance profile for each staphylococcal genome
is computationally predicted and represented as a 0/1 characteristic string where
each character indicates whether this strain is resistant (0 for sensitive; 1 for re-
sistant) to a particular antibiotic. Species in blue represent CA-MRSA strains, in
red represent HA-MRSA strains and in green represent non-human pathogens, lab
strains or strains of uncertain origin.
MRSA. For example, both S. aureus TCH1516 and S. aureus NCTC8325 belong
to ST8 (type 8 of Multi Locus Sequence Typing), but they have distinct antibiotic
resistance phenotypes. To build a reliable phylogenetic tree of all sequenced staphy-
lococcal genomes, we used 31 housekeeping genes as proposed in [136](See methods
for details). The structure is highly consistent with the clonal complex classification
(Table A.1), in which every member of a complex shares six or seven MLST alle-
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les with at least one other member [37], indicating the phylogenetic tree correctly
recovers the evolutionary history. Afterwards, we mapped putative HGT events of
antibiotic resistance genes onto the phylogenetic tree using the following rule. If a
resistance gene is inserted into the same locus within two chromosomes, then we
suggest that these two bacteria share the same HGT origin. In other words, these
two bacteria have diverged after the insertion of resistance gene into their common
ancestor. For example, S. aureus Mu3 and S. aureus Mu50 contain the same tetM
gene, and this gene has been inserted into the same locus of the two chromosomes.
Most of the acquisitions of antibiotic resistance genes and SCCmec elements
occur near or at terminal leave of the phylogenetic tree (Figure A.3), indicating
that these transferable elements are acquired by different staphylococcal lineages
independently and these resistance genes are not native genes in the staphylococ-
cal lineage. The only genes that deviate from this pattern are fosB and mepA
resistance genes indicating that these genes are native to S. aureus strains. FosB
is a metallothiol transferase that confers fosfomycin resistance and has about 60%
percent identity with the fosB gene in Bacillus. MepA is a multi antimicrobial ex-
trusion efflux (MATE) family protein, contributes to the multidrug resistance in
staphylococci [60] and is only identified in S. aureus. These observations indicate
that originally S. aureus strains only contained few resistance genes, and the highly
resistant phenotype was developed through rapid evolution [52].
Different SCCmec elements have been imported eleven times into different





























































































Bacillus subtilis str. 168
(OUTGROUP)
fosB
Figure A.3: Phylogenetic tree of 23 staphylococcal genomes (Bacillus subtilis str.
168 as outgroup) is constructed on the basis of 31 housekeeping marker genes us-
ing neighbor joining. The tree is annotated with horizontal gene transfer events of
antibiotic resistance genes and SCCmec elements. Resistance genes associated with
SCCmec elements are listed in Table S9. The numbers on the intersections indicate
bootstrap value after 100 trials (500 trials performed and normalized to 100), and
bootstrap values below 50 are not indicated. (ant9+ermA)X2 represents that ant9
and ermA resistance genes are located on a same transposon, and these two genes
have been inserted twice in different loci of the chromosome. Blue arrows represent
SCCmec element insertions, yellow hexagons represent plasmid resistance genes ac-
quisition, red round rectangles represent chromosomal resistance genes acquistition
and purple parallelograms represent resistance gene loss from chromosome.
149
dependent occasions through the local acquisitions of SCCmec elements, and could
not have descended from the diversification of a single original MRSA clone. The
resistance genes associated with each SCCmec element are shown in Table S9. The
pUB110 plasmid, which encodes aadD and ble resistance genes, has been integrated
into SCCmec IIa. In addition, both SCCmec IIa and IIb carry the Tn554, a high fre-
quency and site-specific transposable element [8]. In some genomes (e.g., S. aureus
N315), Tn554 has also been inserted multiple times into other loci. Virtually all S.
aureus strains have the potential to acquire resistance to a broad range of antibiotics.
For example, S. aureus MRSA252 is distantly related to other sequenced S. aureus
strains [52], but it has acquired a type II SCCmec element, which is identical with
that from S. aureus Mu3, S. aureus Mu50, and S. aureus N315, and a blaZ gene,
which is widely distributed among S. aureus strains. Antibiotic resistance genes and
SCCmec elements are not shared only within S. aureus strains; they have also been
horizontally transferred to other commensals from the Staphylococcus genus. For
example, compared with its close relative - the non-infectious strain S. epidermidis
ATCC12228 - S. epidermidis RP62A has acquired several antibiotic resistance genes
that have been found in S. aureus and a type II SCCmec element, which is identical
with that from S. aureus JH1 and JH9. S. haemolyticus JCSC1435 has acquired
a novel type SCCmec element, which only carries the mecA resistance gene. How-
ever, it has also acquired eight other antibiotic resistance genes conferring resistance
to all major antibiotics. These observations indicate that HGT of antibiotic resis-
tance genes among multiple staphylococcal species occurs commonly, allowing for
adaptation to shifting host environments.
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Figure A.3 demonstrates marked diversity in the distribution of antibiotic
resistance genes, indicating that mobile DNA is exchanged readily in the S. aureus
population. For example, the type IIa SCCmec element has been found in three
different clonal complexes (CC5, CC30 and CC8; Table A.1). Sometimes it can be
imported into other non aureus staphylococcal species. The heterogeneity of the
genetic background in MRSA, shown in A.3, indicates that many if not all S. aureus
have the potential to become drug resistant. One example is the observation of
the re-emergence of early pandemic S. aureus strains that have acquired mecA and
become a MRSA clone [106]. However, the spread of antibiotic resistance genes does
not correlate with the phylogenetic relationship inferred from the phylogenetic tree
A.3, suggesting that the mobile elements play an important role in facilitating the
rapid changes of drug resistance potential in S. aureus.
A.2.3 HGT of Antibiotic Resistance Genes in Human Staphylococcal
Pathogens Follows Founder Effect
Staphylococci have been shown to be able to acquire resistance genes from the
local habitat, implying the presence of a resistance gene reservoir within staphylo-
cocci or other organisms that co-colonize the same environment or host [46]. To
characterize this antibiotic resistance genes repository, we retrieved from the NCBI
protein database all the resistance genes, belonging to several prevalent types found
in staphylococci. The number and variability of antibiotic resistance genes present
in the natural bacterial populations are huge [81], but only a few are identified in
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staphylococci, especially in human staphylococcal pathogens. In addition, resistance
genes isolated from animal staphylococci are generally more diverse, containing novel
resistance types that are not present in human staphylococcal pathogens. This phe-
nomenon can be described by the ‘founder effect’ model in population genetics,
which refers to the loss of genetic variation when a new colony is established by a
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Figure A.4: Founder effect in the acquisition and distribution of antibiotic resistance
genes in human staphylococcal pathogens. Bottom gray box represents natural bac-
terial populations, and top white box represents human Staphylococcus pathogens.
Resistance gene is represented by circle with name in it. (a) Natural environment
contains various tetracycline resistance genes, but only tetM and tetK are trans-
ferred into the human Staphylococcus pathogens. (b) tetM and tetK resistance
genes are spread in human staphylococcal pathogens, and they also impede the
entrance of other similar tetracycline resistance genes.
In natural environment, more than 30 different types of tetracycline resistance
genes have been found belonging to two functional groups: major facilitator su-
perfamily (MFS) efflux transporter and ribosome protection protein (RPP) [105].
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Only tetK (MFS) and tetM (RPP) resistance types are found and spread in human
staphylococcal pathogen population, although these pathogens have been isolated
from a great variety of locations. TetK is only found and distributed in staphy-
lococci, and all the tetK type genes have very high sequence similarities (>98%).
TetM, a ribosome protection protein, has been identified in more than 20 different
genera (the pairwise similarity ranges from 80% to 100%), but all tetM genes in
staphylococci have very high similarities (>96%). Moreover, tetM resistance genes
isolated from human staphylococcal pathogens from diverse locations have even
higher similarity (>99%). For example, tetM gene NP 390922 isolated from Japan
is exactly the same as gene ACH85960 from Denmark, and is 99% identical with
genes AAA26678 and AAL27024 isolated from US and Poland respectively. TetL is
another MFS type tetracycline resistance gene, and this gene has only been found in
S. hyicus and S. epidermidis from animals. These facts indicate that the tetracycline
resistance genes repository available for human staphylococcal pathogens is limited,
despite the large diversity of these genes within the natural environment.
We further evaluated if the acquisition and distribution of other resistance
genes follow the same pattern as tetracycline resistance genes. mecA is the only
gene responsible for methicillin resistance, and this gene is only found in staphy-
lococci. All mecA genes in human staphylococcal pathogens (including non-aureus
species, such as S. epidermis RP62A and S. haemolyticus JCSC1435) have sequence
similarities above 99%, although some mecA genes isolated from animals and other
environments are more diverse. For example, mecA gene CAJ15584 in S. kloosii
isolated from a horse has only 89% sequence similarity with those isolated from
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human staphylococci. Beta-lactamase resistance genes are generally classified into
4 classes belonging to more than 40 different types [13], but only two types, de-
noted as blaZ1 and blaZ2, have been identified in staphylococci. Only one blaZ2
gene (ABQ23577) has been isolated from staphylococci in an S. epidermis strain,
and this gene is highly prevalent in Klebsiella pneumoniae, indicating this group
of organisms as its probable source [118]. BlaZ1 genes are mostly found in staphy-
lococci (with only two exceptions: AAA24777 and AAB40888 from Enterococcus
faecalis) with high sequences similarities (above 95%), and are widely distributed
in both human and animal staphylococcal pathogens. With regard to macrolide,
lincosamide and streptogramin B antibiotics resistance, about 20 different types of
rRNA methylases (erm) resistance genes are identified, but only four types are found
in staphylococci.
These results indicate that human staphylococcal pathogens generally share
a common source of antibiotic resistance genes, and the exchanges between this
reservoir and other environments are rare. This agrees with the idea that the range
and frequencies of HGT are constrained most often by selective barriers (Kurland, et
al., 2003) between different environments. The reasons for this phenomenon could
be that certain DNA structures favour the combination of certain elements; only
transposable elements and resistance genes coexisting in the same environment are
transferable; and the element conferring a selective advantage quickly spreads and
predominates within the bacterial population under antibiotic threat.
154
A.3 Conclusion
We have investigated the correlation of antibiotic resistance with the adap-
tation of staphylococci in the community and hospital habitats. The analysis is
based on a newly developed antibiotic resistance factors database [81]. Our results
strongly indicate that HA-MRSA strains contain significantly more antibiotic resis-
tance genes than CA-MRSA strains, especially within the main chromosome, which
agrees with previous observations [25]. We propose antibiotic resistance genes in
general as another characteristic marker for the HA- and CA-MRSA strains besides
SCCmec and the PVL element. By mapping the HGT events of antibiotic resis-
tance genes and SCCmec elements onto the phylogenetic tree of Staphylococcus
genomes, we showed that these transposable elements are frequently acquired inde-
pendently, providing the evidence that the emergence of MRSA strains has occurred
repeatedly. In addition, we compared all the antibiotic resistance genes belonging
to several types (tet, mecA, blaZ and erm), and found that only limited versions
of resistance genes are distributed in human staphylococcal pathogens, despite the
fact that some of the strains are isolated from distinct locations.
Since the emerging S. aureus pathogens create profound threats to public
health, tools for rapid detection and characterization of the microbes are a critical
necessity. Functional gene arrays targeting antibiotic resistance and virulence [58]
have been developed as a potential solution. In addition, SCCmec typing [17] and
multi locus sequence typing [36] have been widely used for S. aureus strains, how-
ever because of the rapid evolution of antibiotic resistance, these two methods can
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not fully discriminate and characterize different clones. The analyses described in
this paper indicate that diagnostic assays based on resistance genes could become
a better and more biologically meaningful approach. Because antibiotic resistance
evolves rapidly under drug pressure, it is difficult if not impossible to capture these
characteristics using other marker genes. Typing resistance genes directly not only
provides more discriminatory power, but also gives us an overview of the resistance
profiles, which can be used to design more efficient treatment strategies.
A.4 Materials and methods
A.4.1 Genome Sequences and Annotation
The DNA sequences of 23 Staphylococcus genomes were obtained from the
NCBI genome database. Protein sequences for each genome were extracted from the
corresponding features annotation, and antibiotic resistance genes were annotated
using the tools from Antibiotic Resistance Genes Database [81].
A.4.2 Data Analysis
Using the identified antibiotic resistance genes and the associated resistance
profile, the resistance phenotype for each Staphylococcus strain is represented by a
0/1 characteristic string based on the presence or absence of resistance genes in its
genome. 0 represents sensitive to the antibiotic and 1 represents resistance. The
outgroup is represented by a string with all 0s, indicating it does not contain any
resistance gene. A maximum parsimony tree for the Staphylococcus genomes (Figure
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A.2) was constructed based on these characteristic strings using PHYLIP software
package (pars program), using a maximum parsimony algorithm that minimizes the
number of character state changes, method widely used for morphological data.
The phylogenetic tree in Figure 3 was constructed on the basis of 31 marker
genes [136], with Bacillus subtilis subsp. subtilis str. 168 as an outgroup. The pro-
tein sequences of the marker genes were concatenated accordingly for each genome,
and were aligned using CLUSTALW [124]. Then the alignment was bootstrapped
500 times, and a neighbor-joining tree was constructed and summarized using prot-
dist, neighbor and consense programs in PHYLIP. To visualize the HGT events of
antibiotic resistance genes and SCCmec elements, all of them are painted onto the
phylogenetic tree using the following rule. If two staphylococci share a same re-
sistance gene with same locus on the chromosomes, then we define that these two
bacteria share the same HGT origin. In other words, these two bacteria evolution-
arily diverge after their common ancestor acquires the resistance gene. For example,
S. aureus Mu3 and S. aureus Mu50 contain the same tetM gene, and this gene has
been inserted into the same locus of the two chromosomes, then we define these two
strains share the same tetM insertion origin.
To retrieve all the antibiotic resistance genes belonging to a general type (e.g.
tet, mecA, blaZ and erm), a representative sequence is selected for each subtype of
these four types. There are more than 30 tet subtypes, and we produce a represen-
tative gene sequence for each of them. We focus on subtypes as genes belonging to
a same general type may have very low sequence similarities, although they confer
the same antibiotic resistance phenotype.
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